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Background: A drug-impaired traffic violation is observed every three hours in Canada. Yet, 
there is conflicting evidence to suggest an increased risk of traffic violations in individuals who 
engage in cannabis use.  
 
Objectives: This thesis studied the association between past-year traffic violations and regular or 
occasional use of cannabis among emerging adults (EA). Specifically, the objectives are to: (1) 
estimate the overall, sex-specific, and age-specific prevalence of past-year traffic violations, (2) 
model the association between cannabis use frequency and traffic violations, adjusting for 
potential confounding factors; and, (3) test whether sex, age, regular use of alcohol or other 
drugs, and mood and anxiety disorders moderate the association. 
 
Methods: Data come from the 2012 Canadian Community Health Survey–Mental Health, a 
cross-sectional epidemiological survey. The analytical sample was comprised of 5,630 weighted 
participants categorized as: early EAs (15-19 y), middle EAs (20-24 y), and late EAs (25-29 y). 
Traffic violations were measured using self-report and regular and occasional use of cannabis 
were measured using the CCHS-MH/WHO-CIDI screening method. Weighted logistic 
regression was used to determine adjusted estimates and ensure representativeness. 
 
Results: The prevalence of traffic violations in the analytical sample was 14.7%, was higher for 
males (19.2%), and higher for middle (16.2%) and late (19.4%) EAs. The odds of reporting 
traffic violations were higher for EAs who engaged in regular [OR=1.93 (1.28-2.92)] or 
occasional [OR=1.93 (1.35-2.4)] use of cannabis when compared to EAs who were non-users of 
cannabis. Higher odds of traffic violations were reported in early EAs who engaged in occasional 
use [OR=3.65 (1.96-6.80)] of cannabis and middle EAs who engaged in regular [OR=2.42 (1.37-
4.29)] and occasional [OR=1.70 1.28-3.04)] use of cannabis when compared to their 
counterparts. Moreover, higher odds of traffic violations were reported in EAs who did not 
engage in regular use of other drugs but, who engaged in both regular [OR=1.70 (1.08-2.67)] and 
occasional [OR=1.97 (1.38-2.82)] use of cannabis when compared to their counterparts. 
 
Conclusion: EAs who engage in regular or occasional use of cannabis were shown to have 
increased risk of traffic violations and this finding was augmented across age groups and use of 
other drugs. These findings call for population-based preventative interventions as recreational 
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1.1. Emerging Adulthood 
1.1.1. Theoretical Background 
Emerging adulthood has been proposed as a new period of development for late teens 
through their twenties, specifically ages 18-29 (Arnett, Žukauskienė, & Sugimura, 2014). 
Emerging adults are distinct from children, adolescents, and adults demographically, 
subjectively, and regarding identity explorations (Arnett, 2000). In recent decades, there has been 
a demographic shift in the timing of marriage and adulthood which now take place in the late 
twenties and early thirties (Arnett, 2000). This shift has led emerging adults to explore different 
aspects of their lives. For example, about one third of emerging adults attend a post-secondary 
institute and become semiautonomous, about 40% move out of their parents’ home for full-time 
work, and some emerging adults experience a combination between living at home, going to 
school, and working (Goldschieder & Davanzo, 1986; Goldschieder & Goldschieder 1994). 
Additionally, about two thirds of emerging adults cohabit with a romantic partner (Michael, 
Gagnon, Laumann, & Kolata, 1995). Regarding subjectivity, emerging adults believe they have 
left adolescence but have not yet entered adulthood (Arnett, 2000). For example, when emerging 
adults were asked if they feel they have reached adulthood, the majority answered in some 
respects yes, in some respects no, when compared to just answering yes or no (Arnett, 2001). 
Concerning identity explorations, emerging adults explore emotional and physical intimacy, 
different occupancies and post-secondary majors, and changes in worldviews (Arnett, 2000). 
Moreover, other significant findings in emerging adulthood include increased mental health 
outcomes and risk-taking behaviours. 
 
1.1.2. Mental Health Outcomes 
 Emerging adulthood is a period of self-exploration and experimentation which can be 
overwhelming for an individual. This can often lead to the development of mental health 
disorders, specifically anxiety and mood disorders (Arnett, Žukauskienė, & Sugimura, 2014). For 
example, in the Clark University Poll of Emerging Adults, 72% of respondents answered this 
time of my life is stressful, 56% of respondents answered I often feel anxious, 32% of respondents 
answered I often feel depressed, and 30% of respondents answered I often feel that my life is not 
going well, when asked how they feel about themselves (Arnett, Žukauskienė, & Sugimura, 
2014). Another study determined that perceived adults met the criteria of adulthood, believed 
they had achieved the criteria of adulthood, had better awareness of their identity and romantic 
aspirations, were less depressed, and engaged in fewer risk behaviours than their emerging adult 
peers (Nelson & Barry, 2005). Substance use disorders are also associated with the instability 
and uncertainty of emerging adulthood (Arnett, 2001). For example, substance use peaks during 
emerging adulthood and declines following marriage and parenthood (Arnett, 2001). A more 
recent epidemiological study of substance use disorders among emerging and young adults 
determined that the odds of reporting alcohol or drug abuse/dependence were higher for both 
early emerging adults (15-22 years old) and late emerging adults (23-29 years old) when 
compared with young adults (30-39 years old) (Qadeer, Georgiades, Boyle, & Ferro, 2019). 
 
1.1.3. Risky Driving Behaviour 
 As previously mentioned, there has been a demographic shift in terms of marriage and 
adulthood, such as having children and a stable job, which leaves a period of ambiguity between 
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adolescence and adulthood. During this period, emerging adults experience high rates of risky 
behavior owing to their identity explorations (Arnett, 2001). Specifically, sensation seeking is 
more prevalent in emerging adults because they have become semiautonomous, are less likely to 
be watched by their parents, and are not yet constrained by the responsibilities of adulthood 
(Arnett, 2001). Risky driving behaviours, such as driving at high speeds or while impaired, are 
common among the emerging adult population (Schulenberg, O’Malley, Bachman, Wadsworth, 
& Johnson, 1996). Another study predicting recklessness via four psychosocial predictors (i.e., 
impulsivity, peer pressure, perceived risk, and perceived benefits) in emerging adults found that 
all four psychosocial predictors were associated with reckless driving (Teese & Bradley, 2008).  
 
1.2. Cannabis Use 
1.2.1. Trends  
 In North America, cannabis is the most frequently used illicit drug (UNODC, 2015). In 
Canada, the prevalence of past-year cannabis use increased from 3.6 million users in 2015 (12%) 
to 4.4 million users in 2017 (15%). Higher use is found among males compared to females (19% 
vs. 11%) and younger people (youth 15-19 years, 19%; young adults 20-24 years, 33%; adults 25 
years or older, 13%) (Government of Canada, 2019). These findings are consistent with previous 
reports (Degenhardt & Hall, 2012). While the prevalence of past-year cannabis use for adults 
aged 25 years or older increased from 2015 to 2017, it remained unchanged for youth and young 
adults (Government of Canada, 2019). With recent legalization in Canada and some U.S. states, 
the prevalence of past-year cannabis use is expected to continue trending upward. In Colorado, 
past-year cannabis use in users aged 18-25 has increased from 39% (pre-legalization) to 48% 
(post-legalization) (Substance Abuse and Mental Health Services Administration, 2016). The 
increase in prevalence of past-year cannabis use may be attributable to the decrease in perceived 
risk of cannabis and normalization (Spackman et al., 2017; Hathaway, Mostaghim, Erickson, 
Kolar, & Oborne, 2018; Brochu, Duff, Asbridge, & Erickson, 2011).  
 
1.2.2. Perceptions and Motivations 
 The ‘normalization thesis’ is a theoretical framework used to explain the cultural and 
societal shifts associated with illicit substance use, including cannabis (Parker, Measham, & 
Aldridge, 1995). Moreover, recent research suggests that cannabis use, previously condemned as 
deviant behaviour, has become more tolerable across society (Measham, Newcombe & Parker, 
1994; Duff, 2005; Cheung & Cheung, 2006). Parker and colleagues discovered six indicators of 
substance normalization, they include: (1) better accessibility and availability of the substance, 
(2) higher prevalence rates of the substance, (3) an increasingly positive outlook regarding 
substance use among both users and non-users, (4) substance use expectations among abstainers, 
(5) media influence on substance use, and (6) liberal policy shifts towards legalization (Parker, 
2005). Normalization studies have primarily focussed on youth and adolescents, however recent 
findings reveal homogeneity in cannabis consumption and perceptions about use into young 
adulthood (Duff et al., 2011; Aldridge, Measham, & Williams, 2011). Consequently, cannabis 
normalization has been shown to offset the harms associated with cannabis use based on personal 
experience. For example, participants described health risks (i.e., mood disorders, respiratory 
problems, pregnancy) as less meaningful than the health risks associated with alcohol or tobacco 
and that these risks can be lowered by decreasing the frequency and quantity of cannabis 
consumption (Duff & Erickson, 2014). 
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1.3. Harms Associated with Cannabis Use 
The harms associated with cannabis use are dependent upon dosage, route of 
administration, previous experience, current attitudes and mood, and social setting (Hall & 
Pacula, 2003; WHO, 2016). 
 
1.3.1. Acute Harms 
Acute harms of cannabis, or short-term effects, occur when the associated harm is 
immediately preceded by cannabis exposure (WHO, 2016). Short term effects include impaired 
cognition and coordination (i.e., reduced information processing, perceptual-motor coordination, 
motor performance, attention, and tracking behavior) anxiety and psychotic symptoms (i.e., 
panic attacks and hallucinations), cardiovascular effects (i.e., increased heart rate and blood 
pressure), and traffic injuries and fatalities (Hall & Degenhardt, 2009; Crean, Crane, & Mason, 
2011; Smith, 1968; Pacher & Kunos, 2013; Asbridge, Hayden, & Cartwright, 2012). 
 
1.3.2. Chronic Harms 
 Chronic harms of cannabis, or long-term effects, occur when the associated harm arises 
from regular cannabis exposure, especially daily use, over prolonged periods of time (WHO, 
2016). Long term effects include impaired cognitive function (i.e., lower IQ scores and structural 
changes in the brain), psychosocial consequences (i.e., lack of educational attainment and 
additional substance use), comorbid mental disorders (i.e., schizophrenia, depression, anxiety, 
and bipolar), comorbid physical disorders (i.e., cancer, respiratory, and cardiovascular diseases) 
and dependence (i.e., cannabis use disorder) (Auer et al., 2016; Solowij et al., 2013; Fergusson, 
Boden, & Horwood, 2015; Di Forti et al., 2015; Lai & Sitharthan, 2012; Swift, Hall, Tesson, 
2001; Hall & Pacula, 2010).  
 
1.4. Cannabis Use and Driving 
1.4.1. Current Legislature 
 The legal age to purchase and consume recreational cannabis is 19 years in most 
provinces, with the exception of Alberta and Quebec, in which the legal age is 18 years (Bill C-
45, 2018). 
In most provinces, an individual can obtain a driver’s license (learner’s permit) if they are 
16 years old and accompanied by someone with a full valid driver’s license. However, the 
following are notable exceptions: Alberta, Manitoba and Saskatchewan. In Alberta, an individual 
can obtain a learner’s permit if they are 14 years old and accompanied by someone over the age 
of 18 who is a non-probationary licensed driver (Government of Alberta, 2019). In Manitoba, an 
individual can obtain a learner’s permit if they are 15.5 years old, entered in a driver’s education 
program, and supervised by a driver who has held a full valid driver’s license for 3 or more years 
(Manitoba Public Insurance, 2019). In Saskatchewan, an individual can obtain a learner’s permit 
if they are 15 years old, have parental approval, and are enrolled in a driver’s education program 
(SGI, 2019). 
 There are three federal offences in the Criminal Code of Canada for driving under the 
influence of cannabis, they include: (1) driving with at least 2 nanograms (ng) but less than 5 ng 
of  tetrahydrocannabinol (THC) per millilitre (ml) of blood, (2) driving with 5 or more ng of 
THC per ml of blood, and (3) driving with a combination of 50 or more mg of alcohol plus 2.5 or 
more ng of THC per 1 ml of blood (Bill C-46, 2018). Driving with at least 2 ng but less than 5 ng 
of THC per ml of blood will result in a maximum $1,000 fine. Driving with more than 5 ng of 
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THC per ml of blood or driving with a combination of 50 or more mg of alcohol plus 2.5 or more 
ng of THC per 1 ml of blood will result in a mandatory minimum fine of $1,000 on the first 
offence with increasing severity of penalties for subsequent offences. There is also a zero-
tolerance policy for both young drivers and commercial drivers (Bill C-46, 2018). Both young 
and commercial drivers who violate zero tolerance will be required to pay a $250 fine and have 
their license suspended for 3 days on their first offense (Ministry of Transportation, 2013). If 
convicted in court on the first offense, both young and commercial drivers will be required to 
pay an additional fine up to $500, have their license suspended for a minimum of one year, 
attend an education or treatment program, use an ignition interlock device for a minimum of one 
year, and undergo a mandatory medical evaluation to determine fitness to drive (Ministry of 
Transportation, 2013). The penalties for drug impaired driving and court conviction increase in 
severity for any subsequent offences within 10 years (Ministry of Transportation, 2013). 
 
1.4.2. Screening and Detection  
 Currently, there are four universal methods used to determine cannabis impairment, they 
include: standardized field sobriety tests, drug recognition experts, blood/serum testing, and oral 
fluid testing. 
 Standardized field sobriety tests were originally created to detect impairment by alcohol 
and are comprised of three different tests (i.e., Horizontal Gaze Nystagmus Test, Walk and Turn 
Test, and the One-Leg Stand Test) (Stuster & Burns, 1998). However, research remains mixed 
on whether standardized field sobriety tests can detect cannabis impairment (Bosker et al., 
2012a). For example, dose-dependent dronabinol (synthetic THC) impairment was observed in 
occasional cannabis users and regular cannabis users when compared to a placebo however, the 
results of the standardized field sobriety tests did not reveal cannabis impairment in any of the 
three conditions (Bosker et al., 2012b). In contrast, other studies found that chronic cannabis 
users had higher failure rates on standardized field sobriety tests when compared to a control 
group (Doroudgar et al., 2018; Porath-Waller & Beirness, 2013; Bosker et al., 2012a). Drug 
recognition experts are certified police officers trained to distinguish drug impairment by 
conducting an evaluation of the physical, mental and medical state of a person (Talpins & Hayes, 
2004). A study of 302 cannabis drug recognition expert cases determined that the most common 
predictors of cannabis impairment included increased heart rate, lack of convergence, dilated 
pupils, rebound dilation, and failure to successfully complete 2 of 4 psychological tasks 
(Hartman, Richman, Hayes, & Huetis, 2016). However, both standardized field sobriety tests and 
drug recognition expert examinations fail to meet sensitivity or specificity standards for cannabis 
impairment (Capler, Bilsker, Van Pelt, & MacPherson, 2017) and have not been empirically 
validated for drugs other than alcohol (Bosker et al., 2012a). 
 The biological testing of blood/serum and oral fluid may serve to confirm observations 
from standardized field sobriety tests and drug recognition experts in detecting cannabis 
impairment. However, researchers argue that cannabis impairment cannot be determined by 
specific THC concentrations because: (1) THC concentrations in blood may be considerably less 
at the time of collection since concentration levels drop significantly within the first two hours of 
use (Schwope, Karschner, Gorelick, & Huestis, 2011), (2) THC may be detected in oral fluid by 
passive contamination (Lee & Huestis, 2014), (3) tolerance results in less impairment among 
high frequency cannabis users than low frequency cannabis users at the same dose of THC 
(Reisfield, Goldberger, Gold, & DuPont, 2012), and (4) THC may be present in the blood for 
several days following use (Papafotiou, Carter, Stough, 2005). 
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1.4.3. Perceived Risk 
 According to the Canadian Alcohol and Drug Use Monitoring Survey, approximately 
20% of cannabis users with a valid driver’s license self-reported driving within two hours of 
cannabis consumption in the past year (Health Canada, 2013). Recent studies indicate low 
perceived risk of consequences when driving under the influence of cannabis which may help to 
explain this trend (Goodman, Leos-Toro, & Hammond, 2019; Wickens, Watson, Mann, & 
Brands, 2019; Malhorta, Starkey, & Charlton, 2017; Swift, Jones, & Donnelly, 2010). In a 
Canadian sample of young people (i.e., 16-30 years old), 28% of respondents reported ‘not at all’ 
or ‘a little’ when asked if they believe cannabis increased the risk of a motor vehicle accident 
and 38% of respondents believed that an individual driving under the influence of cannabis 
would be unlikely to be stopped by law enforcement (Goodman, Leos-Toro, & Hammond, 
2019). Moreover, respondents believed that individuals driving under the influence of cannabis 
would be less likely to be charged with an offence and a respondent would be less likely to 
intervene if a friend had used cannabis and was going to drive, when compared to individuals 
driving under the influence of alcohol (Goodman, Leos-Toro, & Hammond, 2019). Another 
factor that leads to decreased perceived risk of driving under the influence of cannabis is the 
absence of social activism and mass-media campaigns related to driving under the influence of 
cannabis compared to driving under the influence of alcohol (i.e., Mothers Against Drunk 
Driving) (McGuire, Dawe, Shield, Rehm, Fischer, 2011). 
 
1.4.4. Perceived Driving Behaviours 
An individual’s perceived driving behaviour has also been associated with driving under 
the influence of cannabis (Watson, Mann, Wickens, & Brands, 2019; Macdonald et al., 2008; 
Terry & Wright, 2005). For example, a study of cannabis users in a remedial program for 
convicted or suspended drivers found that respondents believed driving under the influence of 
cannabis was ordinary and part of their daily routine (Watson, Mann, Wickens, & Brands, 2019). 
Moreover, most respondents reported that they did not have to adjust their driving behaviours to 
offset impairment (Watson, Mann, Wickens, & Brands, 2019). In a similar study, individuals in a 
treatment program for regular use of cannabis who reported no negative effects of cannabis (i.e., 
nervousness, alertness, feeling disoriented, etc.) believed they drove more cautiously, or their 
driving was unaffected while under the influence of cannabis (Macdonald et al., 2008). 
Conversely, reporting negative effects of cannabis was associated with a lower frequency of 
driving under the influence of cannabis (Macdonald et al., 2008).  
 
1.4.5. Driving Performance 
 While individuals feel as though their driving behaviours remain unaffected or improve 
after using cannabis, the literature on cannabis consumption and impaired driving for both 
simulated and actual driving performance remains mixed (Micallef et al., 2018; Doroudgar et al., 
2018; Hartman et al., 2015). For example, a study of moderate (i.e., less than 8 cannabis 
cigarettes per day) and occasional (i.e., smoking THC less than once a month) cannabis smokers 
determined that THC was associated with drowsiness, inappropriate line crossings, and deviation 
of the lateral position of a vehicle in both simulated and actual driving performance (Micallef et 
al., 2018). A study of regular cannabis use and simulated driving performance determined that 
individuals who engage in regular use of cannabis (i.e., using cannabis 4+ days per week) were 
more likely to fail standardized field sobriety tests, had slower reaction times, less standard 
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deviation of speed, and decreased ability to match the lead vehicles speed when compared to 
abstainers (Doroudgar et al., 2018). Comparable effects on driving performance were shown for 
both oral (Bosker et al., 2012b) and vaporized (Arkell et al., 2019; Hartman et al., 2015) 
cannabis consumption. Conversely, a study of individuals who engage in regular use of cannabis 
(i.e., smoking 1 or 2 cannabis cigarettes per day) and occasional use of cannabis (i.e., smoking 1 
or 2 cannabis cigarettes per week) found that occasional use was associated with driving with 
less caution, having poorer driving performance, and having effects of impairment lasting longer 
when compared to regular use, despite individuals who partake in regular use  having higher 
blood concentrations of THC (Hartley et al., 2019). Lower levels of impairment in individuals 
who engage in regular use of cannabis despite high blood concentrations of THC when compared 
to individuals who engage in occasional use of cannabis may be attributed to (1) tolerance; 
namely the reduced responsiveness of the reward circuitry to cannabis intoxication responsible 
for the subjective high and ability to sustain an attention task in a chronic cannabis user (Mason 
et al., 2019) and higher baseline levels of THC in the blood from previous use (Papafotiou, 
Carter, Stough, 2005), ability to compensate for impairment in more experienced cannabis users 
by slowing down and reducing risk-taking behaviours (Smiley, 1986; Kalant & Porath-Waller, 
2019), and (3) differences in smoking and inhalation techniques between regular use and 
occasional use (Fabritius et al., 2013). Studies of biological impairment and driving performance 
have habitually focussed on acute consumption with impairment present when there is  2 ng of 
THC per mL of blood however, future research is warranted on the biological impairment of 
individuals who engage in regular use of cannabis (Hartman & Huestis, 2013). 
 
1.4.6. Traffic Violations  
 A traffic violation occurs when a driver disobeys legislation that regulates the operation 
of vehicles on streets and highways (FindLaw, n.d.). There are two types of traffic violations: 
moving violations and non-moving violations. A moving violation occurs when a driver violates 
laws while the vehicle is in motion, such as failure to stop at a stop sign or a red light, speeding, 
impaired driving, driving with no headlights, and reckless driving (FindLaw, n.d.). A non-
moving violation occurs when a driver violates laws while the vehicle is not in motion, such as 
parking in front of a fire hydrant, in a no parking-zone, in front of an expired meter, and having 
unnecessary muffler noise (FindLaw, n.d.).  
In Canada, a drug-impaired traffic violation is observed every three hours (Statistics 
Canada, 2015). Among drivers arrested for impairment, cannabis is the most frequently detected 
substance succeeding alcohol (Kalant & Porath-Waller, 2019). Moreover, a Canadian study of 
fatal traffic accidents determined that approximately 17% of individuals tested positive for 
cannabis and 40% of the fatalities were in emerging adults aged 16-24 who consumed cannabis 
prior to the crash (Kalant & Porath-Waller, 2019; Beirness, Beasley, & Boase, 2013). However, 
study limitations cannot prove that these fatalities were a result of cannabis impairment (Kalant 
& Porath-Waller, 2019). Little research exists on traffic violations in emerging adults who 
engage in regular or occasional use of cannabis. A study of collisions and traffic violations for 
individuals in treatment for regular substance use (i.e., alcohol, cocaine, and cannabis) found that 
all three treatment groups were more likely to get a traffic violation when compared to matched 
controls (Macdonald, Mann, Chipman, & Anglin-Bodrug, 2004). Similarly, engaging in regular 
cannabis use prior to treatment was significantly associated with “at fault” crashes (Chipman, 
Macdonald, Mann, 2003). Most of the literature highlights the association between acute 
cannabis consumption and risk of a traffic accident, with heterogenous results. A case-crossover 
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study of Canadian drivers determined that the odds of a traffic accident were 4 times higher for 
individuals reporting cannabis use prior to the accident than individuals not reporting cannabis 
use prior to the accident (Asbridge et al., 2014). These findings were similar to other research on 
acute cannabis impairment and risk of a traffic accident (Li et al., 2012). In contrast, a meta-
analysis of acute cannabis impairment and risk of a traffic accident determined that inadequate 
attempt to control for confounding has led to an overestimation of reported associations in the 
literature and that the risk of a traffic accident is not of similar magnitude as seen in alcohol 
impairment (Rogeberg & Elvik, 2016). However, the additive effect of cannabis and alcohol 
increases the risk of a traffic accident substantially (Hartman & Huestis, 2013). 
 
1.5 Theory of Planned Behaviour 
The Theory of Planned Behaviour is a model that was created to help predict when and 
where an individual will engage in a behaviour (Ajzen, 1985). More recently, health 
psychologists have used the Theory of Planned Behaviour to help understand how likely an 
individual will engage in a healthy or unhealthy behaviour based on their perceptions and beliefs 
about the behaviour (LaMorte, 2019). There are three factors which influence an individual’s 
intention to engage in a health behaviour, they are: (1) attitude toward the behaviour, (2) 
subjective norm, and (3) perceived behavioural control. A person’s attitude toward the behaviour 
is influenced by their behavioural beliefs, or what they believe will be the outcome of engaging 
in the behaviour. As previously mentioned, young people in Canada believe that cannabis does 
not increase the risk of a motor vehicle accident and that individuals who drive under the 
influence of cannabis are not likely to be stopped by police (Goodman, Leos-Toro, & 
Hannmond, 2019), thus leading to a positive attitude toward driving under the influence of 
cannabis. Subjective norms are motivated by normative beliefs, or what others think about 
engaging in the behaviour. For example, a study of college students discovered that lower 
perceived risk of penalties and greater perceived acceptance by peers was associated with 
increased likelihood of driving under the influence of cannabis (McCarthy, Lynch, & Pederson, 
2007). An individual’s perceived behavioural control is partial to their control beliefs, or how 
confident an individual feels about engaging in the behaviour, despite barriers which may hinder 
performance. As cited in the literature review, Canadian drivers in a remedial program believed 
that driving under the influence of cannabis was normal and that they did not have to make any 
adjustments to compensate for impairment (Watson, Mann, Wickens, & Brands, 2019). Thus, a 
positive attitude towards the behaviour, favourable subjective norms, and increased perceived 
behavioural control form an intention, which is then succeeded by engagement in the behaviour. 
Moreover, the Theory of Planned Behaviour can be used as a framework to implement 













STUDY RATIONALE & RESEARCH OBJECTIVES 
2.1. Study Rationale 
2.1.1. Addressing the Knowledge Gaps and Problems in Current Research   
 The purpose of the current study was to investigate the association between both regular 
and occasional use of cannabis and traffic violations among emerging adults in a Canadian 
sample. As presented in the literature review, prior research on this topic is limited. The present 
study aimed to address the following knowledge gaps and limitations within the field:  
 
1. Limited research exists on regular use of cannabis and traffic violations. Currently, most 
research is focused on acute impairment and is conducted in laboratory or treatment 
group settings. Some research on regular cannabis use exists, however researchers define 
‘regular use’ differently. Addressing this limitation is vital because individuals who 
engage in regular use of cannabis may have lower levels of impairment despite higher 
blood concentrations of THC when compared to occasional users (Hartley et al., 2019) 
which may be owing to the strategies used by more experienced users to compensate for 
impairment (Smiley 1986; Kalant & Porath-Waller, 2019). This can lead to the unfair 
criminalization of individuals who engage in regular use of cannabis because the current 
policy on cannabis impairment is determined by blood concentrations of THC in addition 
to field sobriety testing. This study can help to understand the association between 
cannabis use frequency and traffic violations from a policy standpoint, to ensure both 
safety and justice for cannabis consumers. 
 
2. Research on regular cannabis use and risk of a traffic violation is mixed. Currently, some 
research demonstrates an association between regular cannabis consumption and traffic 
violations, while other studies show no association. Moreover, research suggests that null 
findings may be owing to tolerance and greater ability to compensate for impairment in 
chronic users when compared to occasional users (Watson, Mann, Wickens, & Brands, 
2019). Addressing this limitation is important because researchers, health care 
professionals, and policy makers are concerned that legalization may be associated with 
an increase in cannabis consumption and thus, an increase in traffic violations. Given that 
the Canadian Community Health Survey – Mental Health (CCHS-MH) data is from 
2012, this study can serve as a framework for future research on cannabis consumption 
and traffic violations when data after legalization becomes available. 
 
3. Adequate controls for known confounders are not included. Currently, studies showing 
associations between cannabis use and traffic violations may be overestimations of 
findings because most do not adequately control for known confounders (Rogeberg & 
Elvik, 2016). Addressing this limitation is imperative to ensure that appropriate findings 
are represented in the literature. The current study aims to address this issue by 
controlling for known confounders as outlined by Rogeberg & Elvic (2016). 
 
4. No research has been conducted within the emerging adult population. Currently, studies 
on the association between cannabis use and traffic violations are conducted in the 
adolescent and adult populations. However, emerging adults are more likely to engage in 
risk behaviours such as increased substance use and impaired driving because they are 
less likely to be monitored by their parents than youth and are not yet obliged by the 
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responsibilities of adulthood. It is important to address this problem because the leading 
cause of injury deaths among young people is unintentional motor vehicle traffic 
accidents (Centers for Disease Control and Prevention, 2019). The current study can help 
to understand if either regular or occasional cannabis use plays a role in this relationship. 
 
2.2. Objectives and Hypotheses 
The current study explored the association between regular or occasional use of cannabis 
and past-year traffic violations among emerging adults (15 to 29 years) using quantitative 
analyses of the CCHS-MH. The objectives of the study and subsequent hypotheses are listed 
below: 
 
2.2.1. Objective 1  
 To estimate the (i) general, (ii) sex-specific, and (iii) age-specific prevalence of past-year 
traffic violations in emerging adults who engaged in regular or occasional use of cannabis when 
compared to emerging adults who were non-users of cannabis. Based on previous research, it 
was hypothesized that the prevalence of past-year traffic violations would be higher among (i) 
emerging adults who engaged in regular or occasional use of cannabis, (ii) male emerging adults, 
and (iii) middle and late emerging adults. 
 
2.2.2. Objective 2  
To model the association between lifetime cannabis use frequency and past-year traffic 
violations among emerging adults, adjusting for potential confounding factors. Given that the 
current research on the association between traffic violations and regular cannabis use is mixed, 
it was hypothesized that the odds of reporting past-year traffic violations would be higher for 
emerging adults who engaged in regular and occasional use of cannabis when compared to 
emerging adults who were non-users of cannabis. 
 
2.2.3. Objective 3  
 To estimate the degree to which (i) sex, (ii) age, (iii) regular use of alcohol, (iv) regular 
use of other drugs, (v) co-morbid mood disorder, and (vi) co-morbid generalized anxiety disorder 
moderate the association between lifetime cannabis frequency (i.e., regular use and occasional 
use) and past-year traffic violations among emerging adults. Based on previous research, it was 
hypothesized that in the presence of each moderator (i.e., male sex, middle and late emerging 
adulthood, regular use of alcohol, regular use of other drugs, co-morbid mood disorder, and co-
morbid generalized anxiety disorder) emerging adults who engaged in regular or occasional use 
of cannabis would have higher odds of reporting traffic violations when compared to emerging 




3.1. Study Design 
 The CCHS-MH was a national study with a cross-sectional design developed by Statistics 
Canada and stakeholders from Health Canada, the Public Health Agency of Canada, the 
Provincial Health Ministries, the Mental Health Commission of Canada, and academic experts 
(Statistics Canada, 2013a). The CCHS-MH was created to understand the mental well-being, 
daily functioning, and access to mental health services and supports of Canadian residents 
(Statistics Canada, 2013a). A three-stage design was used to select the respondents for the study. 
Clusters were selected first, followed by households within each cluster, and finally one 
respondent ≥ 15 years-old was randomly selected (Statistics Canada, 2013a). Geographical 
clusters were selected using the Canadian Labour Force Survey whereby independent samples 
are drawn from homogeneous strata and households are then selected from the corresponding 
household lists for each stratum (Statistics Canada, 2013a). Respondents aged 15 or older were 
randomly selected via a selection probability method. In each household, those ≥ 15 years-old 
were assigned a selection probability factor to help achieve the target population (Statistics 
Canada, 2013a). The selection probabilities assigned to each respondent were as follows: 
multiplicative factor of seven for respondents aged 15-24 and a multiplicative factor of one for 
respondents aged 25-44, 45-64, and 65+ (Statistics Canada, 2013a). After each household 
member was assigned a selection probability, one member of the household was randomly 
selected via a computer program which incorporated the selection probabilities (Statistics 
Canada, 2013a). 
 
3.2. Study Sample  
 The CCHS-MH consisted of 25,113 respondents aged 15 years of age or older living in 
the ten provinces (Statistics Canada, 2013a). Approximately 3% of the target population was 
excluded from this study and included persons living on reserves and in other Indigenous 
communities, full-time members of the Canadian Forces, and the institutionalized population 
(Statistics Canada, 2013a). 
 
3.3. Data Collection 
 The data for the CCHS-MH was collected voluntarily from respondents from January 
2012 to December 2012 (Statistics Canada, 2013a). Prior to interviewing, introductory letters 
and brochures were mailed to the households of the individuals chosen to participate, outlining 
the purpose, importance, and implications of the study (Statistics Canada, 2013a). Following 
introductory letters, interviewers initiated contact with respondents via telephone to arrange an 
in-person interview (Statistics Canada, 2013a). Most interviews (87%) were conducted in the 
respondents’ homes and the remaining interviews were conducted via telephone (Statistics 
Canada, 2013a). Interviews were conducted using computer assisted personal interviewing 
(CAPI), which is an interviewing technique that uses a computer to administer a survey and 
collect responses (Statistics Canada, 2013a, 2017). The computer program also takes an audio 
recording of the respondent while the interviewer inputs the answers to the survey, which can be 
referred to after study completion should any issues arise (Statistics Canada, 2017). The 
interviews were conducted by regional office project managers and senior interviewers for the 




 To ensure that the survey data is nationally represented, a survey weight was given to 
each respondent which corresponds to the number of individuals nationally represented by that 
respondent (Statistics Canada, 2013b). This process was used to control for non-response, 
removal of out-of-scope households, and extreme weight outliers (Statistics Canada, 2013b). 
 
3.3.2. Analytical Sample 
The analytical sample obtained from the CCHS-MH for the purpose of this study 
comprised 5,630 weighted respondents aged 15 to 29 years old. 
 
3.4. Study Measures and Variables 
 
3.4.1. WHO-CIDI 
 The World Health Organization version of the Composite Diagnostic Interview (WHO-
CIDI) was a comprehensive interview used to assess mental disorders and conditions according 
to the definitions and criteria presented in the DSM-IV and ICD-10 (International Statistical 
Classification of Diseases and Related Health Problems – 10th Revision) (Statistics Canada, 
2013b). The criteria for lifetime cannabis dependence, lifetime alcohol abuse or dependence, 
lifetime drug abuse or dependence (excluding cannabis), and lifetime mood disorder as defined 
in the CCHS-MH are comparably enumerated to the DSM-IV however, everyday language was 
used to improve response rate and interpretation of results (Statistics Canada, 2014). Due to the 
minor differences between the CCHS-MH and DSM-IV, it is incorrect to assume an association 
between the two (Statistics Canada, 2014). It is important to note that the sections on lifetime 
cannabis dependence, lifetime alcohol abuse or dependence, lifetime drug abuse or dependence, 
and lifetime mood disorder were measured using the CCHS-MH/WHO-CIDI and not self-report. 
For the purpose of this thesis, the respondents who answered “don’t know/refusal” or did 
not answer the question were excluded from the analyses because they were coded into a single 
variable and thus, cannot be explored independently. 
 
3.4.2. Outcome 
 The outcome, or dependent variable, in this study was self-reported, past-year traffic 
violations. Respondents were asked the following question in a section about contact with police, 
“In the past 12 months, did you come into contact with police for a traffic violation?” proceeded 
by the following answers, “Yes, no, don’t know/refusal” (Statistics Canada, 2011).  
 
3.4.3. Exposure 
 The exposure, or independent variable, in this study was lifetime cannabis use frequency. 
The lifetime cannabis use frequency variable was mutually exclusive and consists of three 
different categories of cannabis users, they include, emerging adults who engaged in regular use 
of cannabis, emerging adults who engaged in occasional use of cannabis, and emerging adults 
who have not currently engaged in cannabis use. These categories were derived from the 
following CCHS-MH variables: lifetime cannabis dependence, lifetime cannabis abuse, lifetime 
cannabis use including one-time use, lifetime cannabis use excluding one-time use, and lifetime 




Lifetime cannabis dependence was classified as a categorical variable and was used to create 
a new category, regular use, in the cannabis use frequency variable. The section relating to 
lifetime cannabis dependence was measured using the CCHS-MH/WHO-CIDI screening 
method. To reduce respondent burden, the section related to cannabis dependence was 
introduced if respondents reported using marijuana more than 50 times in their lifetime. For 
example, “Have you used marijuana or hashish more than 50 times in your lifetime?” proceeded 
by the following answers, “Yes, no, don’t know/refusal” or “In your lifetime, how many times 
have you used marijuana or hashish?” proceeded by the interviewer entering a number between 
2 and 995 (Statistics Canada, 2011). The following was the criteria for the CCHS-MH/WHO-
CIDI that needed to be met to be categorized as having lifetime cannabis dependence: 
 
I. at least three symptoms of cannabis dependence (i.e., tolerance, withdrawal, increased 




II. a maladaptive pattern of cannabis use demonstrated by three or more symptoms occurring 
at the same time, in the same 12-month period (Statistics Canada, 2014). 
Lifetime cannabis abuse was classified as a categorical variable and was used to create a 
new category, regular use, in the cannabis use frequency variable. Lifetime cannabis abuse was 
measured using the CCHS-MH/WHO-CIDI screening method. The section related to cannabis 
abuse was initiated if respondents reported using marijuana or hashish more than once in their 
lifetime. For example, “Have you ever used or tried marijuana or hashish?” proceeded by the 
following answers, “Yes (just once), yes (more than once), no, don’t know/refusal” (Statistics 
Canada, 2011). The following was the criteria for the CCHS-MH/WHO-CIDI that needed to be 
met to be categorized as having lifetime cannabis abuse: 
 




II. experienced at least one of the four symptoms of cannabis abuse (i.e., interfering with 
responsibilities, social problems, continued use despite problems, risk of injury) 
(Statistics Canada, 2014). 
 
Lifetime cannabis use excluding one-time use (more than once) was classified as a 
categorical variable and was used to create a new category, occasional use, in the cannabis use 
frequency variable. ‘More than once use’ was measured using the CCHS-MH/WHO-CIDI 
screening method. Respondents were asked the following question about their use of cannabis, 
“Have you ever used or tried marijuana or hashish?” proceeded by the following answers, “Yes 
(just once), yes (more than once), no, don’t know/refusal” (Statistics Canada, 2014). If 
respondents reported using cannabis more than once, they were categorized into the variable 
which did not include one-time use of cannabis. 
 
Lifetime cannabis use including one-time use (ever use) was classified as a categorical 
variable and was used to create a new category, non-use, in the cannabis use frequency variable. 
 14 
‘Ever use’ was measured using the CCHS-MH/WHO-CIDI screening method. Respondents were 
asked the following question about their use of cannabis, “Have you ever used or tried 
marijuana or hashish?” proceeded by the following answers, “Yes (just once), yes (more than 
once), no, don’t know/refusal” (Statistics Canada, 2014). If respondents reported ever using 
cannabis (i.e., just once or more than once), they were categorized into the variable which 
included one-time use of cannabis. 
 
Lifetime cannabis abstinence (never use) is classified as a categorical variable and was 
used to create a new category, non-use, in the cannabis use frequency variable. ‘Never use’ was 
measured using the CCHS-MH/WHO-CIDI screening method. Respondents were asked the 
following question about their use of cannabis, “Have you ever used or tried marijuana or 
hashish?” proceeded by the following answers, “Yes (just once), yes (more than once), no, don’t 
know/refusal” (Statistics Canada, 2014). If respondents reported never using cannabis, they were 
categorized into the abstinence variable. 
 
3.4.4. Covariates 
Sex was classified as a dichotomous categorical predictor and was measured by asking 
respondents whether they were male or female (Statistics Canada, 2011). 
 
Age was classified as a categorical predictor and was measured by asking respondents 
how old they were. Respondents were categorized by the CCHS-MH into three age groups: 15-
19, 20-24, 25-29 (Statistics Canada, 2011). For the purpose of this thesis, the respondents who 
were categorized in the group of 15-19 year-olds were referred to as early emerging adults, the 
respondents who were categorized into the group of 20-24 year-olds were referred to as middle 
emerging adults, and the respondents who were categorized into the 25-29 year-olds were 
referred to as late emerging adults. 
  
Province of residence was classified as a categorical predictor and was measured by 
asking the respondents what province they are from (Statistics Canada, 2011). For statistical 
analyses, the provinces were grouped by legal driving age. Group one consisted of Alberta, 
Manitoba and Saskatchewan (i.e., legal driving age less than 16 years) and group two consisted 
of British Columbia, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, and 
Newfoundland and Labrador (i.e., legal driving age of 16 years). 
  
Census metropolitan area (CMA) was classified as a dichotomous categorical predictor 
and was measured by asking the respondents if they lived in a CMA vs. if they did not live in a 
CMA (Statistics Canada, 2011).  
 
Lifetime alcohol abuse or dependence was classified as a dichotomous categorical 
predictor and was measured using the CCHS-MH/WHO-CIDI screening method. The CCHS-
MH/WHO-CIDI defined “one drink” as: (i) having one bottle, can, or glass of beer or cooler or 
(ii) one cocktail with 1 ½ ounces of liquor (Statistics Canada, 2011). The section related to 
alcohol abuse was initiated if respondents reported (i) drinking 12 or more drinks in a year (i.e., 
“Have you ever had 12 or more drinks in a year?” proceeded by the following answers, “Yes, 
no, don’t know/refusal”) and (ii) drinking at least once a week (i.e., “Think about the years in 
your life when you drank most. During those years, how often did you usually have at least one 
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drink?” proceeded by the following answers, Less than once a month, once a month, 2 to 3 times 
a month, once a week, 2 to 3 times a week, 4 to 6 times a week, every day”) or drinking 3 or 
more drinks per occasion for less frequent use (i.e., “On the days you drank during those years, 
about how many drinks did you usually have per day” proceeded by the interviewer entering a 
number between 1 and 95) in the year which they drank the most (Statistics Canada, 2011). To 
reduce respondent burden, the section related to alcohol dependence was initiated if respondents 
reported (i) drinking 12 or more drinks in a year and (ii) having 4 or more drinks per week or 
having 5 or more drinks per occasion for less frequent use in the year which they drank the most 
(Statistics Canada, 2011). The following was the criteria for the CCHS-MH/WHO-CIDI that 
needed to be met to be categorized as having lifetime alcohol abuse or dependence: 
 
I. the respondent met the criteria for alcohol abuse: 




b. experienced at least one of the four symptoms of alcohol abuse (i.e., interfering 





II. the respondent met the criteria for alcohol dependence: 
c. at least three symptoms of alcohol dependence (i.e., tolerance, withdrawal, 




d. a maladaptive pattern of alcohol use demonstrated by three or more symptoms 
occurring within a 12-month period (Statistics Canada, 2014). 
 
Lifetime other drug abuse or dependence (excluding cannabis) was classified as a 
dichotomous categorical predictor and was measured using the CCHS-MH/WHO-CIDI 
screening method. The section related to other drug abuse or dependence (excluding cannabis) 
was initiated if the respondent reported using a drug and/or using a prescription drug non-
medically more than once in their lifetime (Statistics Canada, 2011). The CCHS-MH/WHO-
CIDI defined “non-medical drug use” as using a prescription drug without medical advice, using 
a prescription drug more than the recommended dose, or using a prescription drug for any other 
reason than what was suggested by a healthcare professional (Statistics Canada, 2011). The 
drugs groups (not including cannabis) analyzed in the CCHS-MH were sedatives or tranquilizers, 
stimulants, pain killers, cocaine, club drugs, hallucinogens, heroin or opium, and inhalants or 
solvents. The following are the criteria for the CCHS-MH/WHO-CIDI that needed to be met to 
be categorized as having lifetime other drug abuse or dependence: 
 
I. the respondent met the criteria for other drug abuse (excluding cannabis): 





b. experienced at least one of the four symptoms of drug abuse (i.e., interfering with 
responsibilities, social problems, continued use despite problems, risk of injury); 
 
II. the respondent met the criteria for other drug dependence (excluding cannabis): 
a. at least three symptoms of drug dependence (i.e., tolerance, withdrawal, increased 




b. a maladaptive pattern of drug use demonstrated by three or more symptoms 
occurring within a 12-month period (Statistics Canada, 2014). 
  
Any mood disorder (Lifetime) was classified as a dichotomous categorical predictor and 
was measured using the CCHS-MH/WHO-CIDI screening method for major depressive episode, 
bipolar I, bipolar II, and hypomania. A respondent was categorized as having a mood disorder if 
they met the criteria for at least one of the four disorders listed above (Statistics Canada, 2014).  
 
Generalized anxiety disorder (Lifetime) was classified as a dichotomous categorical 
predictor and was measured using the CCHS-MH/WHO-CIDI screening method. A respondent 
was categorized as having generalized anxiety disorder if they reported:  
 
I. excessive anxiety and worry and anxiety about at least two different events or 
activities that lasted at least six months; 
II. finding it difficult to control the worry; 
III. the anxiety and the worry were associated with three or more symptoms associated 
with anxiety; 
IV. the focus of the anxiety and worry was not confined to features of an Axis 1 disorder; 
and 
V. the anxiety, worry, or physical symptoms caused clinically significant distress or 
significant impairment in social, occupational, or other important areas of functioning 
(Statistics Canada, 2014). 
 
3.5. Justification for Grouping ‘Regular Use’ in Cannabis Frequency Variable  
 In the CCHS-MH dataset, respondents were originally categorized as having cannabis 
dependence and abuse. Respondents for both ‘dependence’ and ‘abuse’ were classified as 
engaging in cannabis use more than 50 times in their lifetime and only differed by the symptoms 
which each group experienced. Moreover, this data was collected in 2012 using the DSM-IV and 
the diagnostic criteria has since changed with the new edition. In the DSM-5, cannabis abuse and 
dependence have been merged into one group and the diagnostic criteria for regular cannabis use 
has been reworked (Qadeer, Georgiades, Boyle & Ferro, 2019; American Psychiatric 
Association, 2013). Moreover, both ‘dependence’ and ‘abuse’ do not contribute to stigma-
reducing language. Therefore, a binary logistic regression analysis was conducted to determine if 
the respondents who were categorized as having cannabis dependence and cannabis abuse had 
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statistically different odds of reporting a past-year traffic violations. The results of this analysis 
determined that there was no evidence to support significant difference between groups, as 
shown by the overlapping confidence interval estimates (Appendix B - Table 1). Grouping 
respondents into emerging adults who engage in regular use of cannabis both increases statistical 
power and reduces stigma by incorporating person-first language. Thus, all analyses will be 
conducted using the following three levels of the cannabis use frequency variable: regular use, 
occasional use, non-use. 
 
3.6. Justification for Selected Covariates 
 According to a replication of two published meta-analyses, higher estimates were 
reported on cannabis use and crash risk due to inadequate adjustment of known confounders 
(Rogeberg & Elvik, 2016). A confounder is a variable that causes a spurious association by 
influencing both the independent and dependent variable. Rogeberg & Elvik (2016) determined 
nine confounding variables that should be controlled for when researching cannabis and crash 
risk, they include: age, sex, kilometers driven, drug use history, drug dosage, use of other drugs, 
use of alcohol, health comorbidity, and place of residence (Rogeberg & Elvik, 2016). In the 
current study, all the confounders above have been selected except for kilometers driven and 
drug dosage because these variables were not included in the CCHS-MH. Moreover, age was 
controlled for by looking at early (15-19), middle (20-24), and late (25-39) emerging adults and 
categorizing provinces by driving age, sex was controlled for by including it in the model, drug 
use history was controlled by cannabis use frequency (i.e., emerging adults who engaged in both 
regular and occasional cannabis use), place of residence was assessed by asking the respondents 
if they live in a census metropolitan area, and health comorbidity was assessed by presence of 
comorbid mood disorder and comorbid generalized anxiety disorder. Both mood disorder and 
comorbid generalized anxiety disorder will be used to assess health comorbidity because they are 
known risk factors of traffic violations. For example, a population study of anxiety and mood 
disorders on self-reported traffic violations determined that probable anxiety or mood disorder 
was associated with an increased risk of accident involvement (Wickens et al., 2013). 
 
3.7. Analysis Plan  
 All analyses were conducted using Statistical Analysis System (SAS) (SAS Institute, 
1985) and with a significance level of  = 0.05. The SURVEY procedure was used to ensure that 
the appropriate variance estimators and sampling weights were used when analyzing the CCHS-
MH survey data.  
 
3.7.1. Weighting 
A new sampling weight variable, called WTS_N, was created using the following equation: 
 






WTS_N was the new sampling weight, 
WTS_M was the master sampling weight, and 
?̅?𝑊𝑇𝑆_𝑀 was the average of the master sampling weight (?̅?𝑊𝑇𝑆_𝑀 = 1202.194655)  
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The WTS_N sampling weight was applied to each statistical procedure, so results were 
nationally representative.  
 
3.7.2. Creating a Mutually Exclusive Variable for Cannabis Use Frequency 
 A new variable for cannabis use frequency was created to ensure each dummy variable 
for cannabis frequency (i.e. emerging adults who engaged in regular use of cannabis, emerging 
adults who engaged in occasional use of cannabis, and emerging adults who have not currently 
engaged in the use of cannabis) was mutually exclusive. The new variables were created from 
the following variables in the CCHS-MH: lifetime cannabis dependence, lifetime cannabis 
abuse, lifetime cannabis use including one-time use, lifetime cannabis use excluding one-time 
use, and lifetime cannabis abstinence (Appendix A – Tables 1-3). With reference to the previous 
variable categories, lifetime cannabis dependence and lifetime cannabis abuse were mutually 
exclusive (i.e., a person who was dependent on drugs could not be a person who also abused 
drugs). However, lifetime cannabis abuse and lifetime cannabis use (including one-time use) and 
lifetime cannabis use (excluding one-time use) were not mutually exclusive (i.e., an abuser can 
also be a user). Thus, in order to obtain three mutually exclusive categories for cannabis 
frequency, a four-way cross tabulation analysis using the SURVEYFREQ procedure was used to 
tease out the three cannabis variables listed above (Appendix A – Tables 1-3). 
 
3.7.3. Dummy Variables for Cannabis Use Frequency 
 A dummy variable is a numerical variable that uses values (0,1) to identify categorical 
groups in regression analyses. Two dummy variables were created for cannabis use frequency 
(Appendix C - Table 1). 
 
3.7.4. Reference Categories 
 For lifetime cannabis use frequency, emerging adults who have not currently engaged in 
cannabis use were chosen as the reference category because the current study aims to explore the 
relationship between emerging adults who engaged in regular use of cannabis and traffic 
violations. Thus, in order to determine the impact of the risk factor (i.e., regular use of cannabis) 
and traffic violations, emerging adults who have not currently engaged in cannabis use must be 
set as the reference category because they are not part of the target population represented in the 
research question.  
For sex, females were chosen as the reference category because traffic violations are 
more prevalent in males. Thus, in order to determine the impact of the risk factor (i.e., male sex) 
and traffic violations, females must be set as the reference category because they are not part of 
the target population represented in the research question.  
For age, respondents aged 15-19 years-old were chosen as the reference category because 
there are respondents in this age category who would be classified as a young driver and would 
be accompanied by a more experienced driver. Thus, in order to determine the impact of the risk 
factor (i.e., age) and traffic violations, respondents aged 15-19 years-old must be set as the 
reference category because they are not part of the target population represented in the research 
question.  
For province of residence, group 2 was selected as the reference category because the 
current study aims to determine if a younger legal driving age is associated with an increase in 
self-reporting traffic violations. Thus, in order to determine the impact of the risk factor (i.e., 
legal driving age less than 16 years-old) and traffic violations, provinces that have a legal driving 
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age of 16 must be set as the reference category because they are not part of the target population 
represented in the research question.  
For census metropolitan area, respondents living in a metropolitan area were chosen as 
the reference category because it is assumed that there would be an increased risk of a traffic 
violation (i.e., more roads, increased police presence, more individuals driving, etc.). Thus, in 
order to determine the impact of the risk factor (i.e., living in a rural area) and traffic violations, 
individuals living in an urban area must be set as the reference category because they are not part 
of the target population represented in the research question.  
For lifetime alcohol abuse/dependence, respondents who were not categorized as an 
alcohol abuser/dependent were chosen as the reference category because they are less likely to 
drive impaired and receive a traffic violation than respondents categorized as an alcohol 
abuser/dependent. Thus, in order to determine the impact of the risk factor (i.e., alcohol 
abuse/dependence) and traffic violations, respondents who have not been categorized as an 
alcohol abuser/dependent must be set as the reference category because they are not part of the 
target population represented in the research question.  
For lifetime drug abuse/dependence, respondents who have not been categorized as a 
drug abuser/dependent were chosen as the reference category because they are less likely to drive 
impaired and receive a traffic violation than respondents categorized as a drug abuser/dependent. 
Thus, in order to determine the impact of the risk factor (i.e., drug abuse/dependence) and traffic 
violations, respondents who have not been categorized as a drug abuser/dependent must be set as 
the reference category because they are not part of the target population represented in the 
research question.  
For lifetime mood disorder, respondents who reported not having a mood disorder were 
chosen as the reference category because they are less likely to receive a traffic violation 
compared to respondents diagnosed as having a mood disorder. Thus, in order to determine the 
impact of the risk factor (i.e., presence of a mood disorder) and traffic violations, respondents 
who do not have a mood disorder must be set as the reference category because they are not part 
of the target population represented in the research question.  
For lifetime generalized anxiety disorder, respondents who reported not having 
generalized anxiety disorder were chosen as the reference category because they are less likely to 
receive a traffic violation compared to respondents diagnosed as having generalized anxiety 
disorder. Thus, in order to determine the impact of the risk factor (i.e., presence of generalized 
anxiety disorder) and traffic violations, respondents who do not have generalized anxiety 
disorder must be set as the reference category because they are not part of the target population 
represented in the research question. A summary of the reference categories can be found in the 
appendix (Appendix D - Table 1). 
 
3.7.5. Cross Tabulation Analyses  
 Cross tabulation analyses were conducted to gain an understanding of the analytical 
sample’s descriptive statistics using the weighted frequencies reported from the frequency tables 
in SURVEYFREQ procedure. Frequency tables were reported for univariate exploratory data 
analyses of the outcome, exposure, and covariates (Table 1) and bivariate exploratory data 
analyses between each covariate and the outcome (Table 2). 
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3.7.6. Objective 1 
 The (i) general, (ii) sex-specific, and (iii) age-specific period prevalence of past-year 
traffic violations in emerging adults who engaged in regular or occasional use of cannabis when  
compared to emerging adults who are non-users of cannabis was estimated using the number of 
weighted respondents found in the frequency tables from the SURVEYFREQ procedure (Tables 
1 & 2). The weighted frequencies provided in the previous step were applied to the probability 
tree-diagrams outlined in Figures 1, 2, and 3 (Appendix E). The probability tree diagrams were 
used in the prevalence equations to determine the prevalence (Appendix F). To determine the 
significance between the reported proportions, the Rao-Scott Chi-Square test was used.  
 
3.7.7. Objective 2 
 Hierarchical, binary logistic regression was used to model the association between 
cannabis use frequency and traffic violations among emerging adults, where lifetime cannabis 
use frequency is the categorical variable for exposure and past-year traffic violations is the 
dichotomous categorical variable for the outcome. When conducting analyses, the two dummy 
variables (i.e., emerging adults who engaged in regular or occasional use of cannabis) were used 
in the models. The SURVEYLOGISIC procedure was used to obtain regression estimates and 
odds ratios. Four main effects regression models were used in effort to control for the potential 
effects of covariates by adding covariates into the model sequentially (Appendix G). The 
confounders were added to the unadjusted model in the following blocks: (1) demographic 
characteristics (i.e., sex, age, living in an urban vs. rural area, and province of residence), (2) 
regular substance use (i.e., alcohol and other drugs), and (3) presence of co-morbid mental 
disorder (i.e., mood disorder and generalized anxiety disorder). The hierarchical model compared 
c-statistic values (i.e., estimated area under the ROC curve), odds ratios and 95% confidence 
intervals.  
 
3.7.8. Objective 3 
 The SURVEYLOGISIC procedure was used to estimate the degree to which (i) sex, 
(ii)age, (iii) regular alcohol use, (iv) regular drug use, (v) co-morbid mood disorder, and (vi) co-
morbid generalized anxiety disorder moderate the association between emerging adults who 
engaged in regular or occasional use of cannabis and past-year traffic violations. Specifically, the 
hypothesized model containing all the covariates (Model 4 in Appendix G) with the addition of 
interaction terms was used to test for two-way interactions between (i) cannabis use frequency 
and sex, (ii) cannabis use frequency and age, (iii) cannabis use frequency and regular alcohol 
use, (iv) cannabis use frequency and regular drug use, (v) cannabis use frequency and co-morbid 
mood disorder, and (vi) cannabis use frequency and co-morbid generalized anxiety disorder 
(Appendix H). The joint tests were used to determine if any of the two-way interactions were 
statistically significant (i.e., p < 0.05). If any of the two-way interactions were statistically 





4.1. Study Sample Characteristics 
4.1.1. Univariate Analyses 
Both the sex distribution (i.e., 52.7% male vs. 47.3% female) and age distribution (i.e., 
32.9% early emerging adults vs. 32.0% middle emerging adults vs. 34.1% late emerging adults) 
were similar (Table 1). Respondents were more likely to report non-use of cannabis (58.9%) and 
engaging in occasional use of cannabis (30.2%) when compared to those who reported engaging 
in regular use of cannabis (10.9%). Most respondents reported living in a province with a driving 
age of 16 years old (81.6%) and living in an urban area (77.1%). Engaging in regular use of 
alcohol and drugs other than cannabis was reported for 17.7% and 4.7% of the sample, 
respectively. Additionally, 12.6% of the sample reported having a mood disorder and 6.9% of the 
sample reported having generalized anxiety disorder. 
 
Table 1.  Univariate Exploratory Data Analyses: descriptive statistics for the analytical sample 
(n=5,630).  
 n (%) 
Outcome  
Traffic Violations 830 (14.8) 
Exposure  
Cannabis Use Frequency  
Regular Use 607 (10.9) 
Occasional Use 1683 (30.2) 
Demographic Characteristics  
Male 2969 (52.7) 
Middle EA (20-24 y) 1799(32.0) 
Late EA (25-29 y) 1922 (34.1) 
Province  1035 (18.4) 
Rural 1290 (22.9) 
Substance Use  
Regular Alcohol Use 989 (17.7) 
Regular Drug Use 263 (4.7) 
Mental Disorder  
Mood Disorder 707 (12.6) 
Generalized Anxiety Disorder 387 (6.9) 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. Reported frequencies (n/%) were determined for the outcome, 
exposure, and each covariate. 
 
4.1.2. Bivariate Analyses 
 Reporting a past-year traffic violation was higher among: males (68.5%), emerging adults 
engaging in occasional use of cannabis (42.5%), late emerging adults (44.7%), living in a 
province with a driving age of 16 years old (77.3%), living in an urban area (78.6%), not 
engaging in regular use of alcohol (72.2%) or other drugs (92.3%), and emerging adults without 
a mood disorder (86.6%) or generalized anxiety disorder (93.0%) (Table 2). 
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Table 2. Bivariate Exploratory Data Analysis: descriptive statistics for the analytical sample 
(n=5,630).  
 n (%) 
Exposure  
Cannabis Use Frequency  
Regular Use 143 (17.3) 
Occasional Use 351 (42.5) 
Demographic Characteristics  
Male 569 (68.5) 
Middle EA (20-24 y) 291 (35.1) 
Late EA (25-29 y) 371 (44.7) 
Province  188 (22.7) 
Rural 178 (21.4) 
Substance Use  
Regular Alcohol Use 230 (27.8) 
Regular Drug Use 63 (7.7) 
Mental Disorder  
Mood Disorder 111 (13.4) 
Generalized Anxiety Disorder 58 (7.0) 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. Reported frequencies (n/%) were determined between (i) the 
exposure and outcome and (ii) each covariate and outcome. 
 
4.2. Objective 1 
4.2.1. General Prevalence 
 The prevalence of past-year traffic violations in the total sample was 14.7% and was 
23.8%, 20.8%, and 10.1% for engaging in regular, occasional, and non-use, respectively (Table 
3).  
 
Table 3. General prevalence of past-year traffic violations for the analytical sample (n=5,630). 
Cannabis Use Frequency Traffic Violations 𝝌𝟐 (P-Value) 
Regular Use  143 (23.8) 30.0 (<.001) 
Occasional Use  351 (20.9) 30.1 (<.001) 
Non-Use 331 (10.1) 38.7 (<.001) 
Reported prevalence is presented as n (%). Regular and occasional use of cannabis was compared to non-use. Non-
use was compared to aggregated regular and occasional use. Numbers may not add up to sample because of missing 
data. 
 
4.2.2. Sex-Specific Prevalence 
Overall, the prevalence of past-year traffic violations was highest among male emerging 
adults when compared to female emerging adults (19.2% vs. 9.9%) (Table 4). Males who 
engaged in regular and occasional use of cannabis were more likely to report a traffic violation 
when compared to their female counterparts. Female non-users of cannabis use were more likely 
to report a traffic violation than their male counterparts, however, this finding was not 
statistically significant (p=0.229). Post-hoc comparisons in both males and females revealed 
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significant differences between (i) regular and non-use (p=0.001 males; p=0.005 females), (ii) 
occasional and non-use (p=0.001 males; p<0.001 females), and (iii) non-use and aggregated 
regular and occasional use (p<0.001 males; p<0.001 females).  
 
Table 4. Sex-specific prevalence of past-year traffic violations for the analytical sample 
(n=5,630).  
 Traffic Violations Between Sex 
 Male Female 𝝌𝟐 (P-Value) 
Cannabis Use Frequency    
Regular Use  116 (35.0) 26 (18.1) 6.9 (0.008) 
Occasional Use  237 (52.5) 114 (49.1) 0.2 (0.657) 
Non-Use  214 (37.8) 117 (45.3) 1.5 (0.229) 
Within Sex 𝝌𝟐 (P-Value)    
Regular Use 14.9 (0.001) 8.1 (0.005)  
Occasional Use 13.0 (0.001) 20.0 (<0.001)  
Non-Use 17.3 (<0.001) 21.4 (<0.001)  
Reported prevalence is presented as n (%). Regular and occasional use of cannabis was compared to non-use use. 
Non-use was compared to aggregated regular and occasional use. Post-hoc comparisons were made between regular 
vs. non-use, occasional vs. non-use, and non-use vs. aggregated regular and occasional use for males and females. 
Numbers may not add up to sample because of missing data. 
 
4.2.3. Age-Specific Prevalence 
 The overall prevalence of past-year traffic violations was higher among middle (16.2%) 
and late (19.4 %) emerging adults when compared to early emerging adults (8.8%) (Table 5). 
Middle and late emerging adults who engaged in regular or occasional use of cannabis were 
more likely to report a traffic violation when compared to early emerging adults who engaged in 
regular or occasional use of cannabis. Moreover, early emerging adults were more likely to 
report non-use (50.0%) when compared to middle (36.2%) and late (38.5%) emerging adults. 
However, there was no significant difference between age groups for both occasional (p=0.673) 
and non- (p=0.261) use. Post-hoc comparisons in early emerging adults revealed significant 
differences between: (i) occasional use and non-use (p<0.001) and (ii) non-use and aggregated 
regular and occasional use (p<0.001). However, there was no significant difference observed 
between regular use and non-use. Post-hoc comparisons in middle emerging adults revealed 
significant differences between: (i) regular use and non-use (p<0.001), (ii) occasional use and 
non-use (p=0.001), and (iii) non-use vs. aggregated regular and occasional use (p<0.001). Post-
hoc comparisons in late emerging adults revealed only a significant difference between regular 





Table 5. Age-specific prevalence of past-year traffic violations for the analytical sample 
(n=5,630).  
 Traffic Violations Between Age 
 15-19 Years 20-24 Years 25-29 Years 𝝌𝟐 (P-Value) 
Cannabis Use Frequency     
Regular Use  13 (13.4) 66 (38.8) 64 (31.1) 8.3 (0.016) 
Occasional Use  71 (45.8) 116 (52.5) 164 (53.4) 0.8 (0.673) 
Non-Use  84 (50.0) 104 (36.2) 143 (38.5) 2.7 (0.261) 
Within Age 𝝌𝟐 (P-Value)   
Regular Use 1.3 (0.246) 22.2 (<0.001) 6.5 (0.010)  
Occasional Use 32.2 (<0.001) 12.2 (0.001) 1.9 (0.163)  
Non-Use 24.7 (<0.001) 22.0 (<0.001) 3.5 (0.060)  
Prevalence is presented as n (%). Regular and occasional use of cannabis was compared to non-use use. Non-use 
was compared to aggregated regular and occasional use. Post-hoc comparisons were made between regular vs. non-
use, occasional vs. non-use, and non-use vs. aggregated regular and occasional use for early, middle, and late 
emerging adults. Numbers may not add up to sample because of missing data. 
 
4.3. Objective 2 
 The hierarchical logistic regression model is shown below in Table 6. In the unadjusted 
model, both regular and occasional use of cannabis were significantly associated with a past-year 
traffic violation. However, the odds of reporting a past-year traffic violation were higher for 
emerging adults who engaged in regular use of cannabis when compared to emerging adults who 
engaged in occasional use of cannabis. Model two contained the adjusted model with the 
addition of four demographic characteristics (i.e., sex, age, residing in an urban or rural area, and 
province of residence). In model two, male sex, middle emerging adulthood (i.e., 20-24), late 
emerging adulthood (i.e., 25-29), and living in a province with a driving age < 16 years-old 
significantly increased the odds of reporting a past-year traffic violation. Similar to model one, 
the odds of reporting a traffic violation were higher for emerging adults who engaged in regular 
use of cannabis when compared to emerging adults who engaged in occasional use of cannabis. 
In model three, co-morbid substance use was added to the model and neither regular use of 
alcohol and/or drugs were associated with increased odds of a traffic violation. The effect of 
regular cannabis use seen in models one and two was reduced in model three such that the odds 
of reporting a traffic violation in emerging adults who engaged in regular use of cannabis were 
slightly less than emerging adults who engaged in occasional use of cannabis. In the final model, 
co-morbid mental disorders (i.e., mood disorder and generalized anxiety disorder) were added 
and were not significantly associated with reporting a past-year traffic violation. However, the 
odds of reporting a past-year traffic violation still remained significant for regular and occasional 
use of cannabis. The effect of reporting a traffic violation was the same for emerging adults who 
engaged in both regular and occasional use of cannabis. The overall c-statistic for the final model 




Table 6. Hierarchical logistic regression of cannabis use frequency and traffic violations. 
 Unadjusted Model 2 Model 3  Model 4 
C-Statistic 0.61 0.67 0.67 0.67 
Cannabis Use      
     Regular 2.77 (1.91-4.02) 2.24 (1.53-3.27) 1.92 (1.28-2.89) 1.93 (1.23-2.92) 
     Occasional 2.36 (1.73-3.22) 1.99 (1.42-2.79) 1.93 (1.36-2.74) 1.93 (1.35-2.74) 
Demographics     
     Male  2.03 (1.56-2.65) 2.02 (1.54-2.65) 2.03 (1.55-2.65) 
     Age 20-24  1.68 (1.23-2.29) 1.64 (1.20-2.25) 1.64 (1.20-2.25) 
     Age 25-29  2.03 (1.38-2.99) 2.00 (1.35-2.96) 1.99 (1.35-2.95) 
     Rural   0.90 (0.70-1.17) 0.88 (0.68-1.14) 0.88 (0.68-1.15) 
     Province   1.36 (1.04-1.77) 1.34 (1.03-1.75) 1.34 (1.03-1.76) 
Substance Use     
     Alcohol   1.18 (0.86-1.61) 1.19 (0.87-1.64) 
     Drugs    1.25 (0.79-1.99) 1.27 (0.78-2.04) 
Mental Disorder     
     Mood    0.96 (0.65-1.41) 
     Anxiety    1.00 (0.57-1.75) 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. Values denote Odds Ratio (95% Confidence Interval). 
 
4.4. Objective 3 
The two-way interactions model (Appendix H), which consists of model four, in addition 
to the six interaction terms (i.e., Cannabis Frequency*Sex, Cannabis Frequency*Age, Cannabis 
Frequency*Regular Alcohol Use, Cannabis Frequency*Regular Drug Use, Cannabis 
Frequency*Mood Disorder, and Cannabis Frequency*Generalized Anxiety Disorder), was used 
to determine interaction effects. The results indicated a significant interaction between cannabis 
use frequency and age and a significant interaction between cannabis use frequency and 
engaging in regular use of drugs other than cannabis. The overall c-statistic for the two-way 
interactions model was 0.67, suggesting that the model was a satisfactory fit to the data. 
Pertaining to the observation of two significant interactions, stratified analyses were conducted 




Table 7. Adjusted two-way interactions model of past-year traffic violations. 
Effect  (SE) 
Intercept -1.72 (0.16) 
Regular Use 0.13 (0.19) 
Occasional Use 0.26 (0.19) 
Male 0.36 (0.07) 
Age 20-24 0.14 (0.09) 
Age 25-29 0.33 (0.10) 
Rural -0.06 (0.07) 
Province 0.14 (0.07) 
Regular Use of Alcohol 0.12 (0.09) 
Regular Use of Drugs  -0.08 (0.14) 
Mood Disorder -0.05 (0.10) 
Generalized Anxiety Disorder 0.01 (0.13) 
Sex Interactions  
Regular Use*Male 0.02 (0.11) 
Occasional Use*Male -0.03 (0.09) 
Age Interactions  
Regular Use*Age 20-24 0.24 (0.15) 
Occasional Use*Age 20-24 -0.18 (0.12) 
Regular Use*Age 25-29 0.17 (0.16) 
Occasional Use*Age 25-29 -0.31 (0.13) 
Substance Use Interactions  
Regular Use*Regular Alcohol Use -0.10 (0.13) 
Occasional Use*Regular Alcohol Use -0.07 (0.11) 
Regular Use*Regular Drug Use 0.43 (0.17) 
Occasional Use*Regular Drug Use -0.11 (0.18) 
Mental Disorder Interactions  
Regular Use*Mood Disorder -0.14 (0.15) 
Occasional Use*Mood Disorder 0.20 (0.13) 
Regular Use*Generalized Anxiety Disorder -0.22 (0.18) 
Occasional Use*Generalized Anxiety Disorder -0.12 (0.16) 
C-Statistic = 0.67 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. Values denote  Coefficient (Standard Error). 
 
4.4.1. Stratified Analyses by Age 
I. Early emerging adults (i.e., 15-19) 
There was an association observed between cannabis use frequency and past-year 
traffic violations in early emerging adults. Specifically, the odds of reporting past-year 
traffic violations were higher among early emerging adults who engaged in occasional 
use of cannabis when compared to early emerging adults who were non-users of cannabis 
[OR=3.65 (1.96-6.80)] (Table 8). The overall c-statistic for the binary logistic regression 




Table 8. Unadjusted and adjusted models of past-year traffic violations stratified by early 
emerging adults. 
Effect OR (95% CI)  
Unadjusted   
Regular Use 1.48 (0.76-2.90)  
Occasional Use 4.18 (2.45-7.13)  
 C-Statistic = 0.62 
Adjusted       
Regular Use 1.24 (0.55-2.77)  
Occasional Use 3.65 (1.96-6.80)  
Male 2.04 (1.25-3.31)  
Rural 1.21 (0.74-2.00)  
Province 1.70 (1.01-2.87)  
Regular Use of Alcohol 2.08 (1.01-4.26)  
Regular Use of Drugs  0.35 (0.10-1.27)  
Mood Disorder 0.93 (0.44-2.00)  
Generalized Anxiety Disorder 1.16 (0.26-5.12)  
 C-Statistic = 0.69 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. OR is the odds ratio estimate and CI is the confidence interval. 
 
II. Middle emerging adults (i.e., 20-24) 
There was an association observed between cannabis use frequency and past-year 
traffic violations in middle emerging adults. The odds of reporting past-year traffic 
violations were higher for middle emerging adults who engaged in regular [OR=2.42 
(1.37-4.29)] and occasional [OR=1.70 (1.28-3.04)] use of cannabis when compared to 
middle emerging adults who were non-users of cannabis (Table 9). The overall c-statistic 
for the binary logistic regression model stratified by age was 0.64, suggesting that the 




Table 9. Unadjusted and adjusted models of past-year traffic violations stratified by middle 
emerging adults. 
Effect OR (95% CI)  
Unadjusted   
Regular Use 2.93 (1.85-4.64)  
Occasional use 2.03 (1.34-3.03)  
 C-Statistic = 0.59 
Adjusted       
Regular Use 2.43 (1.37-4.29)  
Occasional Use 2.00 (1.28-3.04)  
Male 1.60 (1.06-2.31)  
Rural 0.95 (0.65-1.37)  
Province  1.53 (1.05-2.22)  
Regular Use of Alcohol 1.08 (0.67-1.76)  
Regular Use of Drugs  1.19 (0.61-2.33)  
Mood Disorder 1.09 (0.63-1.89)  
Generalized Anxiety Disorder 0.86 (0.45-1.66)  
 C-Statistic = 0.64 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. OR is the odds ratio estimate and CI is the confidence interval. 
 
 
III. Late emerging adults (i.e., 25-29) 
There was no association observed between cannabis use frequency and past-year 
traffic violations in late emerging adults. The overall c-statistic for the binary logistic 
regression model stratified by age was 0.63, indicating the model was a satisfactory fit to 




Table 10. Unadjusted and adjusted model of past-year traffic violations stratified by late 
emerging adults. 
Effect OR (95% CI)  
Unadjusted   
Regular Use 2.55 (1.24-5.26)  
Occasional Use 1.52 (0.84-2.74)  
 C-Statistic = 0.57 
Adjusted       
Regular Use 1.66 (0.76-3.61)  
Occasional Use 1.39 (0.76-2.57)  
Male 2.50 (1.54-4.05)  
Rural 0.68 (0.42-1.09)  
Province 1.07 (0.66-1.74)  
Regular Use of Alcohol 1.08 (0.66-1.77)  
Regular Use of Drugs  1.94 (0.94-4.01)  
Mood Disorder 0.88 (0.42-1.83)  
Generalized Anxiety Disorder 1.12 (0.42-2.97)  
 C-Statistic = 0.63 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. OR is the odds ratio estimate and CI is the confidence interval. 
 
4.4.2. Stratified Analyses by Regular Use of Drugs (Excluding Cannabis) 
 
I. Emerging adults who engaged in regular use of drugs other than cannabis 
There was no association observed between cannabis use frequency and past-year 
traffic violations in emerging adults who engaged in regular use of drugs other than 
cannabis. The overall c-statistic for the binary logistic regression model stratified by 
regular use of drugs other than cannabis was 0.65, indicating the model was a satisfactory 




Table 11. Unadjusted and adjusted models of past-year traffic violations stratified by engaging 
in regular use of drugs other than cannabis. 
Effect OR (95% CI)  
Unadjusted   
Regular Use 6.04 (1.48-24.59)  
Occasional use 2.26 (0.54-9.50)  
 C-Statistic = 0.53 
Adjusted       
Regular Use 4.68 (0.88-24.94)  
Occasional Use 1.92 (0.35-10.56)  
Age 20-24 2.42 (1.13-5.22)  
Age 25-29 5.91 (1.40-24.90)  
Male 9.04 (2.23-36.64)  
Rural  1.25 (0.56-2.75)  
Province 0.64 (0.26-1.58)  
Regular Use of Alcohol 0.93 (0.38-2.74)  
Mood Disorder 1.41 (0.51-3.91)  
Generalized Anxiety Disorder 0.39 (0.13-1.18)  
 C-Statistic = 0.65 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old. OR is the odds ratio estimate and CI is the confidence interval. 
 
II. Emerging adults who did not engage in regular use of drugs other than cannabis 
There was an association observed between cannabis use frequency and past-year 
traffic violations in emerging adults who did not engage in regular use of drugs other than 
cannabis. The odds of reporting past-year traffic violations were higher for emerging 
adults who did not engage in regular use of other drugs but, engaged in regular [OR=1.70 
(1.08-2.67)] and occasional use [OR=1.97 (1.38-2.82)] of cannabis when compared to 
emerging adults who did not engage in regular use of drugs and were non-users of 
cannabis (Table 12). The overall c-statistic for the binary logistic model stratified by 
regular use of drugs other than cannabis was 0.67, suggesting the model was a 





Table 12. Unadjusted and adjusted models of past-year traffic violations stratified by not 
engaging in regular use of drugs other than cannabis. 
Effect OR (95% CI)  
Unadjusted   
Regular Use 2.34 (1.57-3.49)  
Occasional use 2.40 (1.74-3.29)  
 C-Statistic = 0.60 
Adjusted   
Regular Use 1.70 (1.08-2.67)  
Occasional Use 1.97 (1.38-2.82)  
Age 20-24 2.00 (1.51-2.66)  
Age 25-29 1.57 (1.14-2.17)  
Male 1.85 (1.23-2.28)  
Rural  0.86 (0.65-1.13)  
Province 1.42 (1.07-1.88)  
Regular Use of Alcohol 1.21 (0.87-1.70)  
Mood Disorder 0.94 (0.62-1.41)  
Generalized Anxiety Disorder 1.21 (0.67-2.18)  
 C-Statistic = 0.67 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 








Given recent legalization in Canada, relevant stakeholders (i.e., researchers, clinicians, 
nurses, and public health professionals) are concerned about the possibility of rising trends in 
driving under the influence of cannabis. This study was the first to examine the association 
between past-year traffic violations and engaging in regular or occasional use of cannabis in the 
emerging adult population. Our findings indicate that regular and occasional use of cannabis 
increased the risk of reporting a traffic violation, and this association was moderated by age and 
use of other drugs. 
 
5.1. Prevalence of Traffic Violations 
 The general prevalence of traffic violations reported in our sample was similar to findings 
in the literature for driving within two hours of consuming cannabis before (14.2%) and after 
(13.2%) legalization (Statistics Canada, 2020). In our study, the prevalence of traffic violations 
was higher for individuals who engaged in regular or occasional use of cannabis when compared 
to individuals who were non-users of cannabis. This finding is similar to other Canadian research 
(Statistics Canada, 2020; Fischer, Rodopoulos, Rehm & Ivsins, 2006; Mann et al., 2007).  
Also comparable to existing data was higher prevalence of traffic violations in males. For 
example, a study analyzing post-legalization data has shown that males were more likely to 
report driving within two hours after using cannabis when compared to females (Statistics 
Canada, 2020). This was similar to the overall sex-specific prevalence of traffic violations found 
in our study. Significant sex-differences for reporting a past-year traffic violation were only 
observed for emerging adults who engaged in regular use of cannabis. Moreover, male emerging 
adults who engaged in regular use of cannabis were more likely to report a traffic violation than 
female emerging adults who engaged in regular use of cannabis. The sizable difference in 
prevalence between males and females may be attributed to the increased likelihood for males to 
engage in risky behaviors when compared to females. For example, males are more likely to 
report aggression, risky driving (Jafarpour & Rahimi-Movaghar, 2014), impulsivity, and regular 
substance use (Waldeck & Miller, 1997) when compared to females. Though not statistically 
significant, females were more likely to report non-use of cannabis compared to males. A 
reasonable explanation for this finding is the increase in proportion of females charged with 
impaired driving from 8% to 20% in 1986 and 2015, respectively (Statistics Canada, 2015).  
With respect to age, the overall prevalence of traffic violations in this study was higher 
for middle and late emerging adults when compared to early emerging adults. Comparable to 
sex, significant age-differences in the prevalence of past-year traffic violations were only 
observed for emerging adults who engaged in regular use of cannabis. In accordance with our 
hypothesis, middle and late emerging adults who engaged in regular use of cannabis were more 
likely to report a traffic violation than early emerging adults who engaged in regular use of 
cannabis. Although no research in emerging adulthood currently exists, higher prevalence of 
traffic violations may be explained by more opportunity to engage in both cannabis use and 
driving throughout the lifetime of middle and late emerging adults. For example, individuals 
aged 20-29 years were more likely to report past-year use (26.1%) and past 3 months use 
(18.7%) when compared to individuals aged 15-19 years who reported past-year use (20.8%) and 
past 3 months use (14.0%) (Leos-Toro, Rynard, & Hammond, 2017). Early emerging adults who 
were non-users of cannabis use were more likely to report a traffic violation when compared to 
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middle and late emerging adults who were non-users of cannabis use; however, this finding was 
not significant. 
 
5.2. Association Between Traffic Violations and Regular or Occasional Use of Cannabis 
 After adjusting for known confounders, there was attenuation in the odds of reporting 
traffic violations such that emerging adults who engaged in regular or occasional use of cannabis 
had the same odds of reporting a past-year traffic violation. A plausible explanation for this 
observation is the development of tolerance in emerging adults who engage in regular use of 
cannabis. Moreover, research suggests that tolerance may explain why some studies fail to show 
clear effects of cannabis impairment in regular users (Ramaekers et al., 2011; Hart et al., 2010). 
For example, a systematic review showed that the acute cognitive effects of cannabis were less 
prominent in regular cannabis users when compared to non-regular users (Colizzi & 
Bhattacharyya, 2018). These less prominent effects can be explained by a reduction in the reward 
circuit pathway responsible for feelings of impairment and cognitive function (Mason et al., 
2019). Regarding driving ability, some evidence suggests that individuals who engaged in more 
frequent use of cannabis revealed less impairment of driving ability when compared to 
individuals who engaged in occasional use of cannabis (Hartley et al., 2019; Newmeyer et al., 
2017). However, other research suggests that engaging in regular use of cannabis is associated 
with driving impairment (Arkell et al., 2019; Doroudgar et al., 2018; Micallef et al., 2018; 
Bosker et al., 2012b) 
 
5.3. Moderating Effects of Age and Other Drug Use 
 Significant moderating effects were observed for age and other drug use. Stratification by 
age revealed higher odds of reporting traffic violations in early emerging adults who engaged in 
occasional use of cannabis. However, non-significant findings were observed for early emerging 
adults who engaged in regular use of cannabis. Early emerging adults may have had less of an 
opportunity to engage in regular use of cannabis over their lifetime. Additionally, early emerging 
adults are still living at home and dependent on their parents leaving little time for 
experimentation (Arnett, 2001). In middle emerging adults, engaging in both regular and 
occasional use of cannabis was associated with increased odds of reporting a traffic violation. 
Increased odds may be related to semi-autonomy during this time. Most emerging adults aged 
20-24 years will have left home for post-secondary education or work and will be experiencing 
living on their own for the first time (Goldschieder & Davanzo, 1986; Goldschieder & 
Goldschieder 1994). This period of self-exploration has been associated with an increase in 
sensation seeking and risky behaviour, such as increased substance use and impaired driving 
(Arnett, 2001). Canadian research has shown that the rate of drug-impaired driving in individuals 
who are 20-24 years old (17 per 100,000) is more than the rate of drug-impaired driving for 
individuals who are 16-19 years old (13 per 100,000) and 25-34 years old (15 per 100,000) 
(Statistics Canada, 2015). Our findings also indicate non-significant findings for late emerging 
adults who engaged in both regular and occasional use of cannabis. A plausible explanation for 
non-significant findings in late emerging adults may be a result of settling down and entering 
adulthood (Arnett, 2001). For example, some emerging adults aged 25-29 years may begin 
graduate or professional studies, become employed full-time, get married, or have children, 
leaving less time for experimentation/risk taking and more time for the obligations and 
responsibilities of adulthood. 
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 Not supported by our hypothesis, stratification by other drug use revealed non-significant 
findings for emerging adults who engaged in regular use of drugs other than cannabis. The null 
finding may indicate that emerging adults who engage in regular use of drugs could have 
suspended licenses for impaired driving and declines in traffic violations might be credited to 
them driving less (Macdonald, Mann, Chipman, & Anglin-Bodrug, 2004). Given the relatively 
wide confidence intervals, the non-significant odds of reporting a traffic violation stratified by 
other drug use may have been attributable to sparse data. Sparse data for other substance use may 
be explained by non-response bias. For instance, research has shown that regular substance users 
tend to be non-respondents (Zhao, Stockwell & MacDonald, 2009; Mann et al., 2002). 
Nonetheless, the effect shown in emerging adults who engaged in both regular use of cannabis 
and other drugs is large and significant effects have been found in the literature (Kleiman, Jones, 
Miller, Halperin, 2018). While other research suggests that engaging in regular polydrug use 
does not increase the risk of an accident when compared to drivers who only engage in regular 
use of one substance (Chipman, Macdonald, & Mann, 2003). Future research should consider 
analyzing the moderating effect of other drug use when studying the association between traffic 
violations and cannabis use frequency to better understand its relationship. Significant findings 
were observed for emerging adults who did not engage in regular use of drugs but engaged in 
regular or occasional use of cannabis. There was a small difference in effect shown between 
regular and occasional use of cannabis. However, attenuation in odds were also shown for 
emerging adults who did not engage in regular use of drugs but engaged in regular use of 
cannabis. The reduction in odds for regular use may be explained by tolerance to the acute 
effects of THC in regular users when compared to occasional users (Hartman & Huestis, 2013; 
Khiabani, Bramness, Bjorneboe & Morland, 2006). To contrast, other literature suggests that less 
tolerance in individuals who engage in regular use of cannabis may be a result of increased 
complexity of the task at hand and thus, requiring multiple neurocognitive and/or neuromotor 









STRENGTHS & LIMITATIONS 
  
6.1. Strengths 
This study has numerous strengths. First, analyses were based on a population-based 
survey in which the findings can be applied broadly. To date, research has been conducted in 
small laboratory or treatment group settings and has not been representative of larger 
populations. Second, this study has been conducted within the emerging adult population which 
has not been examined extensively in the literature despite the fact that emerging adults are more 
likely to engage in risky behaviours. Moreover, the leading cause of injury deaths among 
emerging adults is unintentional motor vehicle traffic accidents (Centers for Disease Control and 
Prevention, 2019) and the third leading cause of non-fatal injuries is unintentional motor vehicle 
occupant (Centers for Disease Control and Prevention, 2017), making research in this population 
imperative. Third, this study can serve as a framework for future research when post-legalization 





Some potential limitations of the study must be noted. First, the outcome of traffic 
violations did not specify if respondents were drivers or passengers, if respondents had valid 
driver’s licences, and the type of stop (i.e., moving/non-moving violation or accident). Second, 
the most recent CCHS-MH data is from 2012 which was before the legalization of cannabis thus, 
respondents may have been reluctant to report their use even if researchers reminded them of 
participant confidentiality. This may have led to underreporting of cannabis use. Third, the 
outcome of traffic violations was measured using self-report. Self-reporting measures may 
increase both social desirability and self-evaluation biases. Moreover, self-reporting traffic 
violations has been shown to decrease validity, with the highest percentage of false self-reporting 
occurring in first time offenders (Chang & Lapham, 1996). Fourth, the results cannot be 
extended out to Indigenous communities, members of the Canadian armed forces, and the 
institutionalized population. These three groups only represent three percent of the Canadian 
population and we cannot ascertain if these respondents may have had comparable findings to 
our sample. Fifth, since non-respondents and respondents with missing data were grouped as one 
variable, we were unable to conduct sensitivity analysis to determine if non-respondents and 
respondents had similar outcomes. However, other research has proven that non-respondents 
tend to be heavier substance users (Mann et al., 2002), indicating possible underestimation of our 
findings. Sixth, the current study is cross-sectional therefore, casual inferences cannot be made 
since temporality cannot be established. However, the results can offer direction for future 
research in longitudinal populations utilizing a cohort study design which assesses the 




7.1.1. Longitudinal Analyses  
This study investigated the association between engaging in regular and occasional use of 
cannabis and past-year traffic violations among early, middle, and late emerging adults. Due to 
the cross-sectional nature of this study, causality could not be determined. Future research should 
investigate the causal relationship between cannabis use frequency and traffic violations in 
emerging adults. As presented in our study and the current literature, the prevalence of traffic 
violations is higher for individuals who engaged in any cannabis use compared to individuals 
who were non-users of cannabis (Fischer, Rodopoulos, Rehm & Ivsins, 2006; Mann et al., 2007). 
However, findings suggesting lower levels of risk for high frequency use remains mixed (Hartley 
et al., 2019). With the increasing concern surrounding cannabis use and driving among health 
professionals, there is an overwhelming demand to understand the temporal relationship between 
frequency of cannabis use and driving. In the current study, the measurement of the outcome and 
exposure has limitations. Currently, Canada does not have access to a roadside survey data 
system which is present in the United States. However, future research could improve the 
outcome of traffic violations by determining the type of violation (i.e., routine traffic stop vs. 
accident), include information on whether or not the driver had a valid license, and if 
respondents were drivers or passengers. While the exposure was measured using the WHO-CIDI 
screening method, the criteria for categorization into ‘dependence’ and ‘abuse’ should be merged 
in accordance with the new criteria and thresholds presented in the DSM-5 (Qadeer, Georgiades, 
Boyle & Ferro, 2019; American Psychiatric Association, 2013). An additional measure to 
determine the potential risk of driving impaired in emerging adults can be assessed by asking 
individuals if they have ever driven within two hours of consuming cannabis. Moreover, 
longitudinal studies can utilize a cohort study design which assesses the trajectories of cannabis 
use over time. Latent class analysis can be used to create groups of emerging adults based on 
their frequency of use, since there is variation in patterns of use in emerging adults. For example, 
a study of cannabis trajectories and associations with driving risk behaviours in Canadian youth 
classified youth into the following groups based off their patterns of use: abstainers, occasional 
users, decreasers, increasers, and chronic users (Sukhawathanakul, Thompson, Brubacher, & 
Leadbeater, 2019). 
 
7.1.2. Natural Experiments 
 While randomized controlled trials (RCT) sit towards the top of the hierarchy of 
scientific evidence, their design is often not considered ethical, practical, or suitable, when 
determining the influence of new legislation (Leatherdale, 2019). The impact of new policy can 
be evaluated by a natural experiment, which is an experiment that doesn’t allow researchers to 
control the implementation of an intervention (Leatherdale 2019; Craig et al., 2012, 2011). 
Currently, driving under the influence of cannabis is tested using RCT designs and driving 
simulators (Arkell et al., 2019; Micallef et al., 2018; Doroudgar et al., 2018; Hartman et al., 
2015; Bosker et al., 2012b). However, findings from these studies may not help to inform real-
world decisions because of discrepancies between real-world driving and simulated driving. 
Future research could explore the impact of driving under the influence of cannabis by assessing 
roadside survey data pre- and post- legalization. For example, a natural experiment in Colorado 
determined that there was no change in the amount that drivers suspected of driving under the 
influence were screened for cannabis, however driving with greater or equal to 2 ng/mL of THC 
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in the blood significantly increased after legalization (i.e., 28% pre- and 65% post- legalization) 
(Urfer, Morton, Beall, Geldmann, & Gunesch, 2014). Similarly, a natural experiment in 
Washington found a significant increase in drivers testing positive for both THC and a THC 
metabolite (carboxy-THC) after legalization (Couper & Peterson, 2014). 
 
7.2. Practice & Prevention 
7.2.1. Theory of Planned Behaviour 
 The Theory of Planned Behaviour was a model used to help explain why emerging adults 
may engage in impaired driving. This study showed that engaging in regular and occasional use 
of cannabis increased the risk of a traffic violation. Our results are supported by the Theory of 
Planned Behaviour. For example, increased prevalence of past-year traffic violations in middle 
and late emerging adults when compared to early emerging adults may be explained by a 
positive attitude towards the behaviour and favorable subjective norms. If middle and late 
emerging adults had a negative attitude towards the behavior and unfavourable subjective norms, 
it would be expected that the prevalence of past-year traffic violations would be less for middle 
and late emerging adults when compared to early emerging adults. Moreover, our findings also 
suggest that tolerance in regular users may explain the reduction in odds when compared to 
occasional users. Also aligned with the theory, tolerance can lead to increased behavioral control. 
For instance, regular cannabis users may be resilient to the acute effects of THC (Hartman & 
Huestis, 2013) and feel they do not need to adjust their driving behaviour to offset impairment 
(Watson, Mann, Wickens, & Brands, 2019), making them feel like they are in complete control. 
While our findings indicate that positive attitude towards the behaviour, favourable subjective 
norms, and increased perceived behavioural control may explain the increased risk of traffic 
violations in regular and occasional cannabis users, this theory should be used to help implement 
population-based interventions to reduce driving impaired by cannabis. 
 
7.2.2. Population-Based Interventions 
The theory of planned behaviour can be a useful tool to help understand perceptions of 
current laws regarding driving under the influence of cannabis. Both qualitative and quantitative 
research have demonstrated an association between lower perceived risk of legal penalties and 
driving under the influence of cannabis when compared to driving under the influence of alcohol 
(Goodman, Leos-Toro, & Hammond, 2019; Terry & Wright, 2005). This perception may be 
attributed to less random roadside testing for cannabis when compared to alcohol, despite having 
laws in place which allow law enforcement to stop and examine drivers (Jones, Donnelly, Swift, 
& Weatherburn, 2005; European Monitoring Centre for Drugs and Drug Addiction, 2003). 
Moreover, current detection methods for cannabis impairment have not been empirically 
validated (Bosker et al., 2012a) and do not meet sensitivity or specificity requirements (Capler, 
Bilsker, Van Pelt, & MacPherson, 2017), which could lower perceived risk by impacting both 
behavioural and normative beliefs. Lower perception of risk may also be influenced by tolerance 
in high frequency users who believe they do not have to acclimatize to compensate for 
impairment (Watson, Mann, Wickens, & Brands, 2019). Thus, population-based interventions 
should keep the following two recommendations in mind: (1) increase risk perception by 
improving random roadside testing for cannabis; and (2) defining per se laws for driving under 
the influence of cannabis once more research becomes available so high frequency users do not 
run the risk of unlawful criminalization. 
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Understanding the theory of planned behavior can help public health professionals create 
and implement mass-media campaigns. Applying the theory of planned behaviour, an individual 
is more likely to drive under the influence of cannabis if they have positive attitudes the 
behaviour (i.e., believing that the risks of driving under the influence of cannabis are low), 
favourable subjective norms (i.e., friends and family also believe that the risks of driving under 
the influence are low), and increased perceived behaviour control (i.e., believing that cannabis 
does not impair their ability to drive). Aforementioned, the lack of mass media campaigns for 
driving under the influence of cannabis may be associated with reduced social stigma when 
compared to driving under the influence of alcohol (McGuire, Dawe, Shield, Rehm, Fischer, 
2011). In Colorado, a mass-media campaign called “Drive High, Get a DUI” was implemented 
in 2014 (Brooks-Russell, Levinson, Li, Roppolo, & Bull, 2017). A large prospective cohort 
evaluating the effectiveness of the campaign determined that cannabis users who reported seeing 
the campaign at least once were significantly more likely to have an accurate understanding of 
the new legislation when compared to cannabis users who never reported seeing the campaign 
[OR=2.53 (1.29-4.95)] (Brooks-Russell, Levinson, Li, Roppolo, & Bull, 2017). Moreover, other 
research suggests that knowledge of Colorado legislature is a weak predictor of driving under the 
influence of cannabis (Davis et al., 2016). However, data generated from the research conducted 
by Davis and colleagues was limited to an online convenience sample and may not be 
representative of larger populations (Davis et al., 2016). Nonetheless, there is strong evidence to 
suggest that mass-media campaigns are effective at reducing substance impaired driving (Young 










 Since the legalization of cannabis, driving under the influence of cannabis has become a 
chief public health concern in Canada. The shortage of research on traffic violations among 
emerging adults who engage in regular or occasional use of cannabis emphasizes the importance 
of understanding this relationship and if tolerance plays a role in reducing the risk of a traffic 
violation. The findings presented in this thesis can be used as a paradigm for future research in 
longitudinal populations and natural experiments to evaluate the impact of cannabis legalization 
in Canada and other large populations. The results of this study can also offer recommendations 
for population-based interventions targeting regular and occasional cannabis users by utilizing 
the Theory of Planned Behaviour model to help understand how individual beliefs, social norms, 
and perceived risks can influence intention to engage in impaired driving. The implications of 
population-based interventions such as improving random roadside drug testing, defining per se 
laws, and creating mass-media campaigns can help reduce the prevalence of traffic violations 
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Appendix A – Variables Used to Create New Cannabis Frequency Variable 
 







Frequency (n) Percent (%) 
Yes Yes 163 100 
 No 0 . 
 Total 163 100 
No Yes 0 . 
 No 0 . 
 Total 0 . 
*Table of Cannabis Use Excluding One-Time Use versus Cannabis Use Including One-Time Use, controlling for 











Frequency (n) Percent (%) 
Yes Yes 444 100 
 No 0 . 
 Total 444 100 
No Yes 0 . 
 No 0 . 
 Total 0 . 
*Table of Cannabis Use Excluding One-Time Use versus Cannabis Use Including One-Time Use, controlling for 




Table 3. Reported frequencies (n/%) to determine Lifetime Cannabis Use**, One-Time Use***, 







Frequency (n) Percent (%) 
Yes Yes 1683** 33.8 
 No 0 . 
 Total 1683** 33.8 
No Yes 498*** 10.0 
 No     2792**** 56.1 
 Total                 3290 66.2 
*Table of Cannabis Use Excluding One-Time Use versus Cannabis Use Including One-Time Use, controlling for 
Lifetime Cannabis Dependence = ‘No’ and Lifetime Cannabis Abuse = ‘No’. 
**Lifetime Cannabis Users 
***Lifetime Cannabis One-Time Users 
****Lifetime Cannabis Abstainers  
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Appendix B – Grouping ‘Regular Use’ in Cannabis Frequency Variable  
 
Table 1. Adjusted models of past-year traffic violations for merging cannabis frequency groups 
and keeping groups separate. 
Merging Groups (i.e., ‘Regular Use’) Keeping Groups Separate (i.e., ‘Dependence’ 
and ‘Abuse’) 
Effect OR (95% CI) Effect OR (95% CI) 
Regular Use 1.93 (1.23-2.92) 
 
Dependence 2.37 (1.25-4.48) 
Abuse 1.82 (1.16-2.84) 
Occasional Use 1.93 (1.35-2.74) Occasional Use 1.93 (1.35-2.75) 
Male 2.03 (1.55-2.65) Male 2.03 (1.55-2.65) 
Age 20-24  1.64 (1.20-2.25) Age 20-24  1.63 (1.19-2.24) 
Age 25-29  1.99 (1.35-2.95) Age 25-29  1.99 (1.35-2.94) 
Rural 0.88 (0.68-1.15) Rural 1.13 (0.87-1.47) 
Province 1.34 (1.03-1.76) Province 1.35 (1.03-1.77) 
Regular Alcohol Use 1.19 (0.87-1.64) Regular Alcohol Use 1.19 (0.87-1.64) 
Regular Drug Use 1.27 (0.78-2.04) Regular Drug Use 1.21 (0.76-1.92) 
Mood Disorder 0.96 (0.65-1.41) Mood Disorder 0.95 (0.65-1.41) 
Generalized Anxiety 
Disorder 
1.00 (0.57-1.75) Generalized Anxiety 
Disorder 
1.00 (0.57-1.74) 
Province refers to province group 1 which consists of Alberta, Saskatchewan and Manitoba. All three provinces 
have a legal driving age that is less than 16 years old.   
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Appendix C – Dummy Variables for Cannabis Use Frequency 
 
Table 1. Dummy variables for cannabis use frequency. 
Cannabis Use Frequency Dummy Value 
Lifetime Cannabis Dependence 1 0 
Lifetime Cannabis Abuse 0 1 
Lifetime Cannabis Abstinence (Reference) 0 0 
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Appendix D – Reference Categories 
 
Table 1. Summary of reference categories that will be used for each variable during statistical 
analyses. 
Variable Reference Category 
Lifetime Cannabis Use Frequency People who have not engaged in cannabis use 
Sex Female 
Age 15-19 
Province of Residence Group 2 
Census Metropolitan Area People who live in a census metropolitan area 
Lifetime Alcohol Abuse/Dependence No 
Lifetime Drug Abuse/Dependence No 
Lifetime Mood Disorder No 
Lifetime Generalized Anxiety Disorder No 
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Appendix E – Probability Tree Diagrams for Prevalence 
 
Figure 1. Probability tree-diagram using the weighted frequencies for each cannabis use 
frequency category (i.e., regular use, occasional use, and non-use) obtained in cross tabulation 




















Figure 2. Probability tree-diagram using the weighted frequencies for each cannabis use 
frequency category (i.e., regular use, occasional use, and non-use) obtained in cross tabulation 




Figure 3. Probability tree-diagram using the weighted frequencies for each cannabis use 
frequency category (i.e., regular use, occasional use, and non-use) obtained in cross tabulation 




Appendix F – Prevalence Calculations 
 
i. General Period Prevalence  
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑟𝑒𝑔𝑢𝑙𝑎𝑟)  =  
# 𝑜𝑓 𝑟𝑒𝑔𝑢𝑙𝑎𝑟 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 ℎ𝑒𝑎𝑣𝑦 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙)  =  
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑛𝑜𝑛)  =  
# 𝑜𝑓 𝑛𝑜𝑛 − 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛




ii. Sex-Specific Period Prevalence 
a. Female Prevalence 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑟𝑒𝑔𝑢𝑙𝑎𝑟)  =  
# 𝑜𝑓 𝑟𝑒𝑔𝑢𝑙𝑎𝑟 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 ℎ𝑒𝑎𝑣𝑦 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙)  =  
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑛𝑜𝑛)  =  
# 𝑜𝑓 𝑛𝑜𝑛 − 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛




b. Male Prevalence 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑟𝑒𝑔𝑢𝑙𝑎𝑟)  =  
# 𝑜𝑓 𝑟𝑒𝑔𝑢𝑙𝑎𝑟 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 ℎ𝑒𝑎𝑣𝑦 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙)  =  
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑛𝑜𝑛)  =  
# 𝑜𝑓 𝑛𝑜𝑛 − 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛




iii. Age-Specific Period Prevalence 
a. Early Emerging Adults (15-19) 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑟𝑒𝑔𝑢𝑙𝑎𝑟)  =  
# 𝑜𝑓 𝑟𝑒𝑔𝑢𝑙𝑎𝑟 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 ℎ𝑒𝑎𝑣𝑦 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙)  =  
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑛𝑜𝑛)  =  
# 𝑜𝑓 𝑛𝑜𝑛 − 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛





b. Middle Emerging Adults (20-24) 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑟𝑒𝑔𝑢𝑙𝑎𝑟)  =  
# 𝑜𝑓 𝑟𝑒𝑔𝑢𝑙𝑎𝑟 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 ℎ𝑒𝑎𝑣𝑦 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙)  =  
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑛𝑜𝑛)  =  
# 𝑜𝑓 𝑛𝑜𝑛 − 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛




c. Late Emerging Adults (25-29) 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑟𝑒𝑔𝑢𝑙𝑎𝑟)  =  
# 𝑜𝑓 𝑟𝑒𝑔𝑢𝑙𝑎𝑟 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 ℎ𝑒𝑎𝑣𝑦 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙)  =  
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛
# 𝑜𝑓 𝑜𝑐𝑐𝑎𝑠𝑖𝑜𝑛𝑎𝑙 𝑢𝑠𝑒𝑟𝑠
 
 
𝑝𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 𝑜𝑓 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛𝑠 (𝑛𝑜𝑛)  =  
# 𝑜𝑓 𝑛𝑜𝑛 − 𝑢𝑠𝑒𝑟𝑠 𝒘𝒊𝒕𝒉 𝑎 𝑡𝑟𝑎𝑓𝑓𝑖𝑐 𝑣𝑖𝑜𝑙𝑎𝑡𝑖𝑜𝑛












𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 ; 
where  
𝜂𝑖 is the observed log odds of past-year traffic violations for subject i.  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, and 
for any 𝑖 ≠ 𝑗, (𝑋𝑖 , 𝑌𝑖) ⊥ (𝑋𝑗 , 𝑌𝑗). 
 
 
Model 2  
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6X6𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐴𝐺𝐸𝑖 + 𝛽5𝐶𝑀𝐴𝑖 + 𝛽6𝑃𝑅𝑂𝑉𝑖; 
where  
𝜂𝑖 is the observed log odds of past-year traffic violations for subject i.  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed dummy variable for age for subject i, 
𝑋5𝑖 is the observed predictor of census metropolitan area i, 
𝑋6𝑖 is the observed predictor of province for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use,  
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to age, 
𝛽5 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽6 is the fixed unknown regression coefficient corresponding to province, and 




Model 3  
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐴𝐺𝐸𝑖 + 𝛽5𝐶𝑀𝐴𝑖 + 𝛽6𝑃𝑅𝑂𝑉𝑖 +
𝛽7𝐴𝐿𝐶𝑖 + 𝛽8𝐷𝑅𝑈𝐺𝑖; 
where  
𝜂𝑖 is the observed log odds of past-year traffic violations for subject i.  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed dummy variable for age for subject i, 
𝑋5𝑖 is the observed predictor of census metropolitan area i, 
𝑋6𝑖 is the observed predictor of province for subject i, 
𝑋7𝑖 is the observed predictor of regular alcohol use for subject i, 
𝑋8𝑖 is the observed predictor of other regular drug use for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to age, 
𝛽5 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽6 is the fixed unknown regression coefficient corresponding to province,  
𝛽7 is the fixed unknown regression coefficient corresponding to regular alcohol use, 
𝛽8 is the fixed unknown regression coefficient corresponding to regular drug use, and 




𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖 + 𝛽9𝑋9𝑖 +
𝛽10𝑋10𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐴𝐺𝐸𝑖 + 𝛽5𝐶𝑀𝐴𝑖 + 𝛽6𝑃𝑅𝑂𝑉𝑖 +
𝛽7𝐴𝐿𝐶𝑖 + 𝛽8𝐷𝑅𝑈𝐺𝑖 + 𝛽9𝑀𝑂𝑂𝐷𝑖 + 𝛽10𝐺𝐴𝐷𝑖; 
where  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed dummy variable for age for subject i, 
𝑋5𝑖 is the observed predictor of census metropolitan area i, 
𝑋6𝑖 is the observed predictor of province for subject i, 
𝑋7𝑖 is the observed predictor of regular alcohol use for subject i, 
𝑋8𝑖 is the observed predictor of regular drug use for subject i, 
𝑋9𝑖 is the observed predictor of mood disorder for subject i, 
𝑋10𝑖 is the observed predictor of generalized anxiety disorder for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to age, 
𝛽5 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽6 is the fixed unknown regression coefficient corresponding to province,  
𝛽7 is the fixed unknown regression coefficient corresponding to regular alcohol use, 
𝛽8 is the fixed unknown regression coefficient corresponding to regular drug use,  
𝛽9 is the fixed unknown regression coefficient corresponding to mood disorder,  
𝛽10 is the fixed unknown regression coefficient corresponding to generalized anxiety disorder, 
and 




Appendix H – Hypothesized Two-Way Interactions Model 
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖 + 𝛽9𝑋9𝑖 +
𝛽10𝑋10𝑖 + 𝛽11𝑋1𝑋3𝑖 + 𝛽12𝑋1𝑋4𝑖 + 𝛽13𝑋1𝑋7𝑖 + 𝛽14𝑋1𝑋8𝑖 + 𝛽15𝑋1𝑋9𝑖 + 𝛽16𝑋1𝑋10𝑖 + 𝛽17𝑋2𝑋3𝑖 +
𝛽18𝑋2𝑋4𝑖 + 𝛽19𝑋2𝑋7𝑖 + 𝛽20𝑋2𝑋8𝑖 + 𝛽21𝑋2𝑋9𝑖 + 𝛽22𝑋2𝑋10𝑖; 
 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐴𝐺𝐸𝑖 + 𝛽5𝐶𝑀𝐴𝑖 + 𝛽6𝑃𝑅𝑂𝑉𝑖 +
𝛽7𝐴𝐿𝐶𝑖 + 𝛽8𝐷𝑅𝑈𝐺𝑖 + 𝛽9𝑀𝑂𝑂𝐷𝑖 + 𝛽10𝐺𝐴𝐷𝑖 + 𝛽11𝑅𝐸𝐺𝑈𝐿𝐴𝑅 ∗ 𝑆𝐸𝑋𝑖 + 𝛽12𝑅𝐸𝐺𝑈𝐿𝐴𝑅 ∗
𝐴𝐺𝐸𝑖 + 𝛽13𝑅𝐸𝐺𝑈𝐿𝐴𝑅 ∗ 𝐴𝐿𝐶𝑖 + 𝛽14𝑅𝐸𝐺𝑈𝐿𝐴𝑅 ∗ 𝐷𝑅𝑈𝐺𝑖 + 𝛽15𝑅𝐸𝐺𝑈𝐿𝐴𝑅 ∗ 𝑀𝑂𝑂𝐷𝑖 +
𝛽16𝑅𝐸𝐺𝑈𝐿𝐴𝑅 ∗ 𝐺𝐴𝐷𝑖 + 𝛽17𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿 ∗ 𝑆𝐸𝑋𝑖 + 𝛽18𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿 ∗ 𝐴𝐺𝐸𝑖 +
𝛽19𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿 ∗ 𝐴𝐿𝐶𝑖 + 𝛽20𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿 ∗ 𝐷𝑅𝑈𝐺𝑖 + 𝛽21𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿 ∗ 𝑀𝑂𝑂𝐷𝑖 + 
𝛽22𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿 ∗ 𝐺𝐴𝐷𝑖 ; 
 
where  
𝜂𝑖 is the observed log odds of past-year traffic violations for subject i.  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed dummy variable for age for subject i, 
𝑋5𝑖 is the observed predictor of census metropolitan area i, 
𝑋6𝑖 is the observed predictor of province for subject i, 
𝑋7𝑖 is the observed predictor of regular use of alcohol for subject i, 
𝑋8𝑖 is the observed predictor of regular use of drugs for subject i, 
𝑋9𝑖 is the observed predictor of mood disorder for subject i, 
𝑋10𝑖 is the observed predictor of generalized anxiety disorder for subject i, 
𝑋11𝑖 is the observed predictor for the interaction term of regular use and sex for subject i, 
𝑋12𝑖 is the observed predictor for the interaction term of regular use and age for subject i, 
𝑋13𝑖 is the observed predictor for the interaction term of regular use and regular use of alcohol 
for subject i, 
𝑋14𝑖 is the observed predictor for the interaction term of regular use and regular use of drugs for 
subject i, 
𝑋15𝑖 is the observed predictor for the interaction term of regular use and mood disorder for 
subject i, 
𝑋16𝑖 is the observed predictor for the interaction term of regular use and generalized anxiety 
disorder for subject i, 
𝑋17𝑖 is the observed predictor for the interaction term of occasional use and sex for subject i, 
𝑋18𝑖 is the observed predictor for the interaction term of occasional use and age for subject i, 
𝑋19𝑖 is the observed predictor for the interaction term of occasional use and regular use of 
alcohol for subject i, 
𝑋20𝑖 is the observed predictor for the interaction term of occasional use and regular use of drugs 
for subject i, 
𝑋21𝑖 is the observed predictor for the interaction term of occasional use and mood disorder for 
subject i, 
𝑋22𝑖 is the observed predictor for the interaction term of occasional use and generalized anxiety 
disorder for subject i, 
𝛽0 is the fixed unknown intercept, 
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𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to age, 
𝛽5 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽6 is the fixed unknown regression coefficient corresponding to province,  
𝛽7 is the fixed unknown regression coefficient corresponding to regular alcohol use, 
𝛽8 is the fixed unknown regression coefficient corresponding to regular drug use,  
𝛽9 is the fixed unknown regression coefficient corresponding to mood disorder,  
𝛽10 is the fixed unknown regression coefficient corresponding to generalized anxiety disorder,  
𝛽11𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of regular 
use and sex for subject i, 
𝛽12𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of regular 
use and age for subject i, 
𝛽13𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of regular 
use and regular alcohol use for subject i, 
𝛽14𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of regular 
use and regular drug use for subject i, 
𝛽15𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of regular 
use and mood disorder for subject i, 
𝛽16𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of regular 
use and generalized anxiety disorder for subject i, 
𝛽17𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of 
occasional use and sex for subject i, 
𝛽18𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of 
occasional use and age for subject i, 
𝛽19𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of 
occasional use and regular alcohol use for subject i, 
𝛽20𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of regular 
drug use for subject i, 
𝛽21𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of 
occasional use and mood disorder for subject i, 
𝛽22𝑖 is the fixed unknown regression coefficient corresponding to the interaction term of 
occasional use and generalized anxiety disorder for subject i, and 








Early Emerging Adults (15-19 y) 
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖 + 𝛽9𝑋9𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐶𝑀𝐴𝑖 + 𝛽5𝑃𝑅𝑂𝑉𝑖 + 𝛽6𝐴𝐿𝐶𝑖 +
𝛽7𝐷𝑅𝑈𝐺𝑖 + 𝛽8𝑀𝑂𝑂𝐷𝑖 + 𝛽9𝐺𝐴𝐷𝑖 ; 
where  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed predictor of census metropolitan area i, 
𝑋5𝑖 is the observed predictor of province for subject i, 
𝑋6𝑖 is the observed predictor of regular use of alcohol for subject i, 
𝑋7𝑖 is the observed predictor of regular use of drugs for subject i, 
𝑋8𝑖 is the observed predictor of mood disorder for subject i, 
𝑋9𝑖 is the observed predictor of generalized anxiety disorder for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽5 is the fixed unknown regression coefficient corresponding to province,  
𝛽6 is the fixed unknown regression coefficient corresponding to regular use of alcohol, 
𝛽7 is the fixed unknown regression coefficient corresponding to regular use of drugs,  
𝛽8 is the fixed unknown regression coefficient corresponding to mood disorder,  
𝛽9 is the fixed unknown regression coefficient corresponding to generalized anxiety disorder, 
and 









Middle Emerging Adults (20-24 y) 
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖 + 𝛽9𝑋9𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐶𝑀𝐴𝑖 + 𝛽5𝑃𝑅𝑂𝑉𝑖 + 𝛽6𝐴𝐿𝐶𝑖 +
𝛽7𝐷𝑅𝑈𝐺𝑖 + 𝛽8𝑀𝑂𝑂𝐷𝑖 + 𝛽9𝐺𝐴𝐷𝑖 ; 
where  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed predictor of census metropolitan area i, 
𝑋5𝑖 is the observed predictor of province for subject i, 
𝑋6𝑖 is the observed predictor of regular use of alcohol for subject i, 
𝑋7𝑖 is the observed predictor of regular use of drugs for subject i, 
𝑋8𝑖 is the observed predictor of mood disorder for subject i, 
𝑋9𝑖 is the observed predictor of generalized anxiety disorder for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽5 is the fixed unknown regression coefficient corresponding to province,  
𝛽6 is the fixed unknown regression coefficient corresponding to regular use of alcohol, 
𝛽7 is the fixed unknown regression coefficient corresponding to regular use of drugs,  
𝛽8 is the fixed unknown regression coefficient corresponding to mood disorder,  
𝛽9 is the fixed unknown regression coefficient corresponding to generalized anxiety disorder, 
and 






Late Emerging Adults (25-29 y) 
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖 + 𝛽9𝑋9𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐶𝑀𝐴𝑖 + 𝛽5𝑃𝑅𝑂𝑉𝑖 + 𝛽6𝐴𝐿𝐶𝑖 +
𝛽7𝐷𝑅𝑈𝐺𝑖 + 𝛽8𝑀𝑂𝑂𝐷𝑖 + 𝛽9𝐺𝐴𝐷𝑖 ; 
where  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed predictor of census metropolitan area i, 
𝑋5𝑖 is the observed predictor of province for subject i, 
𝑋6𝑖 is the observed predictor of regular use of alcohol for subject i, 
𝑋7𝑖 is the observed predictor of regular use of drugs for subject i, 
𝑋8𝑖 is the observed predictor of mood disorder for subject i, 
𝑋9𝑖 is the observed predictor of generalized anxiety disorder for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽5 is the fixed unknown regression coefficient corresponding to province,  
𝛽6 is the fixed unknown regression coefficient corresponding to regular use of alcohol, 
𝛽7 is the fixed unknown regression coefficient corresponding to regular use of drugs,  
𝛽8 is the fixed unknown regression coefficient corresponding to mood disorder,  
𝛽9 is the fixed unknown regression coefficient corresponding to generalized anxiety disorder, 
and 
for any 𝑖 ≠ 𝑗, (𝑋𝑖 , 𝑌𝑖) ⊥ (𝑋𝑗 , 𝑌𝑗). 
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By Regular Use of Other Drugs 
 
Regular Use of Other Drugs = YES 
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖 + 𝛽9𝑋9𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐴𝐺𝐸𝑖 + 𝛽5𝐶𝑀𝐴𝑖 + 𝛽6𝑃𝑅𝑂𝑉𝑖 +
𝛽7𝐴𝐿𝐶𝑖 + 𝛽8𝑀𝑂𝑂𝐷𝑖 + 𝛽9𝐺𝐴𝐷𝑖 ; 
where  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed dummy variable for age for subject i, 
𝑋5𝑖 is the observed predictor of census metropolitan area i, 
𝑋6𝑖 is the observed predictor of province for subject i, 
𝑋7𝑖 is the observed predictor of regular use of alcohol for subject i, 
𝑋8𝑖 is the observed predictor of mood disorder for subject i, 
𝑋9𝑖 is the observed predictor of generalized anxiety disorder for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to age, 
𝛽5 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽6 is the fixed unknown regression coefficient corresponding to province,  
𝛽7 is the fixed unknown regression coefficient corresponding to regular use of alcohol, 
𝛽8 is the fixed unknown regression coefficient corresponding to mood disorder,  
𝛽9 is the fixed unknown regression coefficient corresponding to generalized anxiety disorder, 
and 




Regular Use of Other Drugs = NO 
 
𝜂𝑖 =  𝛽0 + 𝛽1X𝑖 + 𝛽2𝑋2𝑖 + 𝛽3𝑋3𝑖 + 𝛽4𝑋4𝑖 + 𝛽5X5𝑖 + 𝛽6𝑋6𝑖 + 𝛽7𝑋7𝑖 + 𝛽8𝑋8𝑖 + 𝛽9𝑋9𝑖; 
𝜂𝑖 =  𝛽0 + 𝛽1𝑅𝐸𝐺𝑈𝐿𝐴𝑅𝑖 + 𝛽2𝑂𝐶𝐶𝐴𝑆𝐼𝑂𝑁𝐴𝐿𝑖 + 𝛽3𝑆𝐸𝑋𝑖 + 𝛽4𝐴𝐺𝐸𝑖 + 𝛽5𝐶𝑀𝐴𝑖 + 𝛽6𝑃𝑅𝑂𝑉𝑖 +
𝛽7𝐴𝐿𝐶𝑖 + 𝛽8𝑀𝑂𝑂𝐷𝑖 + 𝛽9𝐺𝐴𝐷𝑖 ; 
where  
𝑋1𝑖 is the observed dummy variable for regular use, 
𝑋2𝑖 is the observed dummy variable for occasional use, 
𝑋3𝑖 is the observed dummy variable for sex for subject i, 
𝑋4𝑖 is the observed dummy variable for age for subject i, 
𝑋5𝑖 is the observed predictor of census metropolitan area i, 
𝑋6𝑖 is the observed predictor of province for subject i, 
𝑋7𝑖 is the observed predictor of regular use of alcohol for subject i, 
𝑋8𝑖 is the observed predictor of mood disorder for subject i, 
𝑋9𝑖 is the observed predictor of generalized anxiety disorder for subject i, 
𝛽0 is the fixed unknown intercept, 
𝛽1 is the fixed unknown regression coefficient corresponding to regular use,  
𝛽2 is the fixed unknown regression coefficient corresponding to occasional use, 
𝛽3 is the fixed unknown regression coefficient corresponding to sex,  
𝛽4 is the fixed unknown regression coefficient corresponding to age, 
𝛽5 is the fixed unknown regression coefficient corresponding to census metropolitan area,  
𝛽6 is the fixed unknown regression coefficient corresponding to province,  
𝛽7 is the fixed unknown regression coefficient corresponding to regular use of alcohol, 
𝛽8 is the fixed unknown regression coefficient corresponding to mood disorder,  
𝛽9 is the fixed unknown regression coefficient corresponding to generalized anxiety disorder, 
and 
for any 𝑖 ≠ 𝑗, (𝑋𝑖 , 𝑌𝑖) ⊥ (𝑋𝑗 , 𝑌𝑗). 
 
 
 
 
